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3 Research integrity 
Summary
Research is fundamental to the process of pushing back the frontiers of human 
knowledge and understanding. Research helps cure diseases, tackle climate change, and 
understand the world around us. The UK has an enviable reputation for high-quality 
research, and researchers are among the most trusted groups of people in the eyes of 
the public. It is recognised that the vast majority of research undertaken in the UK is of 
high quality and high integrity.
Nevertheless, error, questionable practices, and outright fraud are possible in any 
human endeavour, and research integrity must be taken seriously and tackled head-
on. The 2012 Concordat to Support Research Integrity provided a set of high-level 
commitments in this vein, but, six years on, while all the most research intensive-
universities are complying with key recommendations of the Concordat, around a 
quarter of universities overall are not fulfilling the basic Concordat recommendation of 
producing an annual report on research integrity.
Compliance with the Concordat has technically been a prerequisite for receiving 
funding from UK research councils and higher education funding councils since 2013, 
but non-compliance has not led to any hard consequences. This reflects the fact that 
the Concordat has only high-level commitments and recommendations, meaning that 
‘compliance’ is difficult to assess in practice. More broadly, there has been a lack of co-
ordinated leadership to drive the implementation of its recommendations in universities, 
such as transparency in declaring the number of misconduct investigations carried out 
each year. The Concordat should be tightened so that compliance can be more easily 
assessed, with a timetabled route-map to securing 100% compliance. We welcome 
Universities UK’s plans to convene a meeting of the Concordat signatories to discuss 
the issues raised in our report and look forward to seeing further action in this area.
The current lack of consistent transparency means that it is impossible to assess the scale 
of the research integrity issue, leading to accusations that parts of the sector are policing 
themselves in a secretive way in order to maintain its reputation or, worse, a perception 
that investigations are not conducted properly in order to avoid embarrassment. 
Meanwhile, there is a risk that a future high-profile scandal could expose any weaknesses 
in this arrangement. Fraud appears to be rare, but the number of institutions reporting 
no investigations each year does not tally with other available information—the self-
reported pressures on researchers to compromise on standards, an increase in the rate 
of journal articles being retracted, and a growth in image manipulation in articles. 
Part of the cause may be a lack of understanding of the principles of statistics among 
researchers, and greater emphasis should be placed on statistical rigour. The sector 
needs to see increased transparency and reporting of problems as a positive sign that 
issues are being identified and dealt with accordingly, rather than as a threat.
We see a gap in the UK research integrity system for a new committee to provide 
a means of independently verifying whether a research institution has followed 
appropriate processes in investigating misconduct, following similar models in Canada 
and Australia. The primary responsibility to investigate misconduct should remain with 
the employer, but there is also a need to improve confidence in the existing system of 
self-regulation and to adjust for the potential conflict of interest of ‘self-policing’. More 
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broadly, the new committee should be responsible for championing research integrity 
in the sector, driving the future implementation of a tightened Research Integrity 
Concordat, and pursuing issues we identify in this report. The new committee will need 
to be established by and work closely with UK Research and Innovation, and produce an 
annual report on the state of research integrity in the UK. This is an opportunity for the 
research community to get ahead of this issue; without such a body being established, 
there is a risk that the demand for statutory regulation will grow in response to any 
future scandals, despite a consensus against such regulation within the community.
Meanwhile, there are other steps that can be taken to support research integrity rather 
than simply responding to problems. We are encouraged to hear that research integrity 
will form part of the ‘environment’ judgements for the next Research Excellence 
Framework, and that there are moves towards appropriate publishing of datasets, 
and better reporting of research methods. Meanwhile, UKRI needs to understand 
how the pressures and incentives within the research funding system affect research 
behaviour and consider where counterbalances are needed to ensure a healthy research 
culture. Training is key to ensuring that the right research culture is imbued by each 
new generation of researchers and their supervisors, and to ensuring that errors such 
as common misuses of statistics are avoided. In order to increase the effectiveness of 
research, increased emphasis should be put on the need to publish ‘negative’ research 
findings, especially in the field of medicine.
Employers, funders and publishers of research need to be able to share information to 
support investigations of misconduct, and it is encouraging that protocols are being 
developed to help employers to manage cases which cross institutional boundaries.
5 Research integrity 
1 Introduction
1. Research is fundamental to the process of pushing back the frontiers of human 
knowledge and understanding. Research helps cure diseases, tackle climate change, and 
understand the world around us. Research will help the UK to tackle the grand challenges 
of society—an ageing population, how to take care of the Earth’s ecosystem, and how to 
make the most of ‘big data’, to name just a few. The Prime Minister has recently described 
scientific research as “a noble pursuit and a public good”.1
2. Problems with the integrity of research—when research is anything less than 
“rigorous, accurate, honest and transparent”2—can arise from errors, poor research 
design, or even outright fraud. All of these problems have the potential to tarnish the 
reputation of research, and erroneous deductions and conclusions can have dramatic 
consequences, particularly in the context of medical research. Meanwhile, increasing sums 
of public money are being invested in research and development, and the Government has 
committed to increasing public and private spending on research and development to 
2.4% of GDP by 2027, with total public investment reaching £12.5bn in 2021/22.3
3. In 2011 a previous Science and Technology Committee held an inquiry into ‘Peer 
review in scientific publications’, which explored research integrity in the context of the 
publishing process.4 The Committee concluded that the general oversight of research 
integrity in the UK was “unsatisfactory”, and recommended that an external regulator for 
research integrity should be established.5
4. This recommendation was not taken up by the Government.6 Instead, in 2012 
Universities UK (UUK) coordinated the establishment of a ‘Concordat to Support 
Research Integrity’,7 to articulate “a set of common expectations and commitments in a 
comprehensive and coherent national policy framework” and provide “a clear stimulus 
for concerted action”.8 UUK reported in 2016 on progress in implementing the Concordat 
over the preceding four years.9
Our inquiry
5. In January 2017 our predecessor Committee launched a follow-up inquiry into 
research integrity, to coincide with the publication of a briefing on this topic from the 
Parliamentary Office of Science and Technology (POST).10 The Committee called for 
written submissions on the issues identified in the POST briefing, including:
1 “PM speech on science and modern Industrial Strategy: 21 May 2018”, gov.uk (accessed 22 May 2018)
2 Nuffield Council on Bioethics (RIN0089) para 7
3 “Record boost to R&D and new transport fund to help build economy fit for the future”, Gov.uk, 20 November 
2017
4 Science and Technology Committee, Eighth Report of Session 2010–12, Peer review in scientific publications, HC 
856
5 Science and Technology Committee, Eighth Report of Session 2010–12, Peer review in scientific publications, HC 
856, paras 262 & 271
6 Science and Technology Committee, Tenth Special Report of Session 2010–12, Peer review in scientific 
publications: Government and Research Councils UK responses to the Committee’s Eighth Report of Session 
2010–12, HC 1535
7 Universities UK, The Concordat to Support Research Integrity (July 2012)
8 Universities UK (RIN0057) para 9
9 Universities UK, The Concordat to Support Research Integrity: A Progress Report (November 2016)
10 Integrity in Research, POSTnote 544, Parliamentary Office of Science and Technology, January 2017
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• The extent of the research integrity problem;
• Causes and drivers of recent trends;
• The effectiveness of controls/regulation (formal and informal), and what further 
measures if any are needed;
• What matters should be for the research/academic community to deal with, and 
which for Government.
That inquiry was ended prematurely by the dissolution of Parliament for the General 
Election in 2017. We decided to continue this inquiry in the new Parliament, drawing on 
the 82 submissions to our predecessors and a further 48 accepted and published by us.11 
We held six oral evidence sessions, hearing from 27 witnesses. We are grateful for all these 
contributions to our work.
6. We did not seek to investigate specific allegations of research misconduct or to re-
open old cases. We and our predecessor Committee rejected several written submissions 
on that basis. However, a small number of cases are referred to in our report where they 
illustrate current issues relating to research integrity.
The Science Minister’s reluctance to give oral evidence
7. We invited a Government Minister to provide oral evidence to our inquiry, and 
initially arranged to take evidence from Jo Johnson MP, the then Minister for Universities, 
Science, Research and Innovation, on 6 February 2018. Following the Government reshuffle 
in January, we agreed with the new Minister’s office (Sam Gyimah MP) to defer this 
session until 6 March, to accommodate the new Minister’s existing diary commitments. 
At the new Minister’s request, we agreed that Sir Mark Walport (Chief Executive, UK 
Research and Innovation) should accompany him that day. A few days before the session, 
the Minister told us that he would not now be attending, since it would be “a better use 
of Committee Members’ time” to direct our questions to Sir Mark instead.12 His letter 
could have been interpreted to suggest that he did not see a role for the Government in 
this area, since “the terms and conditions applied to researchers [are] the responsibility 
of the funders, employers and researchers themselves and I do not believe that this is best 
furthered by direct intervention from Government”.13 After our session with Sir Mark, 
the Minister gave evidence for our separate inquiry into Brexit, science and innovation, 
and we took this opportunity to ask him to reflect on his decision not to attend to discuss 
research integrity. He claimed that his non-attendance was merely “a suggestion, not a 
refusal”,14 and subsequently he gave evidence to our inquiry two months later, on 8 May.
8. The Science Minister’s initial reluctance to give evidence to our inquiry was 
disappointing, not least as it risked sending the message that the Government does 
not take this issue seriously. Nevertheless, we welcome the fact that that the Minister 
was subsequently willing to appear and are grateful for his responses to our questions.
11 Written submissions to our predecessor’s inquiry (i.e. those received before the General Election) are labelled 
with ‘RIN’ numbers; submissions received in the current Parliament are labelled with the ‘RES’ prefix.
12 Letter from Sam Gyimah MP to Rt Hon Norman Lamb MP, February 2018
13 Letter from Sam Gyimah MP to Rt Hon Norman Lamb MP, February 2018
14 Oral evidence taken on 6 March 2018, HC 705, Q1
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9. The Government rightly invests considerable sums of public money in research, 
and investment in research and development as a proportion of GDP is set to grow 
further in the coming years. The Government needs to be confident that all possible 
steps are being taken to ensure that this money is not wasted through problems with 
research integrity, and that the research that it buys is as reliable as possible. While the 
Government should not seek to interfere directly in research matters or compromise 
the independence of universities, it should nevertheless maintain an active interest 
in supporting research integrity and ensuring that all elements of self-regulation are 
functioning well in order to get the best value possible from public investment.
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2 Understanding and measuring 
‘research integrity’
Definitions
10. The Concordat to Support Research Integrity15 lists the core elements of research 
integrity as:
• Honesty in all aspects of research, including in the presentation of research 
goals, intentions and findings; in reporting on research methods and procedures; 
in gathering data; in using and acknowledging the work of other researchers; 
and in conveying valid interpretations and making justifiable claims based on 
research findings;
• Rigour, in line with prevailing disciplinary norms and standards: in performing 
research and using appropriate methods; in adhering to an agreed protocol where 
appropriate; in drawing interpretations and conclusions from the research; and 
in communicating the results;
• Transparency and open communication in declaring conflicts of interest; in the 
reporting of research data collection methods; in the analysis and interpretation 
of data; in making research findings widely available, which includes sharing 
negative results as appropriate; and in presenting the work to other researchers 
and to the general public; and
• Care and respect for all participants in and subjects of research, including 
humans, animals, the environment and cultural objects.
11. Our inquiry focused on understanding and categorising the problem of research or 
researchers falling short of these expectations—that is, where there is a lack of research 
integrity. Within this, the written evidence we received encouraged us to distinguish 
between:
• Research misconduct, often defined by “falsification, fabrication and plagiarism” 
(FFP), which includes making up data or results, manipulating research 
materials, equipment, or processes, or changing or omitting data or results;16
• “Questionable Research Practices” (QRPs), a much wider group of 
misdemeanours, poor research design and other unhealthy practices—some 
of which may be deployed in ignorance of the potential consequences for the 
integrity of the research rather than attempt to mislead (see Box 1); and
• Errors such as miscalculation or mismeasurement which may compromise the 
research record.
12. We were also encouraged to distinguish between the integrity of researchers and the 
integrity of the research itself.17 Indeed, while there have been high-profile examples of 
15 Universities UK, The Concordat to Support Research Integrity (July 2012), p11
16 Office of Research Integrity, ‘Definition of Research Misconduct’, (accessed 10 May 2018)
17 Q2 [Professor Dorothy Bishop]
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deliberate fraud, there are also examples of researchers correcting their own honest errors 
in order to protect the integrity of the published research base. Professors Lewandowksy 
and Bishop told us that “errors are unavoidable in any human endeavour”, and that while 
“in the past, discovery of an error in a scientist’s work was regarded as a source of shame”, 
it is now recognised that “the sign of a good scientist is one who promptly recognises 
errors and corrects the public record; this is increasingly seen as a sign of integrity that 
actually can enhance a person’s reputation”.18
Box 1: Questionable Research Practices
Questionable Research Practices (QRPs) include design, analytic, or reporting 
practices that could be employed with the purpose of presenting biased evidence 
in favour of an assertion. Examples include selectively reporting hypotheses with 
a preference for those that are statistically significant, and ‘‘cherry picking’’ data. 
Other typical QRPs might include rounding down a ‘p value’ (a measure of statistical 
significance) in order to report a significant result. These practices can occur with 
or without an intent to deceive; for instance, deliberately excluding an outlier 
from an analysis could change the conclusions, but this could be done for sound 
methodological reasons and be reported transparently, or could be employed for the 
express purpose of turning non-significant result into a significant one.
We were pointed specifically to the practices of ‘p-hacking’ and ‘HARKing’ as 
examples of QRPs. P-hacking refers to the practice of running multiple tests, looking 
for a statistic that surpasses the threshold for statistical significance, and reporting 
only this. The problem is that by running multiple analyses, a researcher will increase 
the likelihood of finding a statistically significant result by chance alone. For example, 
if a researcher was studying the relationship between a gene and a set of 20 different 
personality questionnaires (all filled in by multiple participants) and did not adjust 
their significance threshold to take into account the fact that they are running so 
many tests, it would be expected that at least one of the personality questionnaires 
would have a statistically significant relationship to the gene at the 0.05 level, even if 
in reality there is no relationship. The likelihood that none of the variables will reach 
the 0.05 level of significance is (1−0.95)N, where N is the number of measures. So with 
10 measures, there is a 40% chance that at least one measure will be ‘significant’; with 
20 measures this rises to 64%. There are various ways of correcting for this issue of 
multiple comparisons.
P-hacking is often coupled with HARKing, i.e. hypothesising after the results are 
known—here, the researcher invents a plausible-sounding explanation for the result 
that was obtained, after the data have been inspected.19
Sources: Banks et al, “Editorial: Evidence on Questionable Research Practices: The Good, the Bad and the Ugly”, Journal 
of Business Psychology, 20116; Academy of Medical Sciences, Reproducibility and reliability of biomedical research: 
improving research practice (October 2015), p20
18 Professor Stephan Lewandowsky and Professor Dorothy Bishop (RIN0046) para 20
19 Academy of Medical Sciences, Reproducibility and reliability of biomedical research: improving research practice 
(October 2015), p20
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13. A further threat to the integrity of research is ‘publication bias’—the tendency for 
positive results to be published over negative or inconclusive findings, and therefore for 
some research outcomes to go unpublished altogether. Dr Ben Goldacre argued that this 
distortion of the published evidence base was a more significant issue than academic 
misconduct:
Fraud is not the most important issue. The culture of incomplete and 
inaccurate reporting of research has greater impact on patients and society 
[…] [Clinical] Trials are large expensive research projects used to generate 
knowledge that is then used, in clinical practice, to make vitally important 
decisions; and yet trials are commonly left unreported, or misreported. 
This is a waste of money, and distorts the evidence underpinning medical 
practice.20
Indeed, the Concordat to Support Research Integrity (see Chapter 3) notes that “refusing 
to publish negative research findings” is “harmful to the reputation and quality of UK 
research, and to the research record”.21 Publication bias arises particularly in relation 
to clinical trials, and the drivers of non-publication of results can include commercial 
interests and the relative value placed on “flashy breakthrough-type results”22 over other 
outcomes (see Chapter 4). Our predecessor Committee examined the issue of clinical trials 
transparency in 201323 and, given the significance of this topic as a public health issue, we 
will publish a separate report on clinical trials transparency and medical research later 
this year, drawing on the evidence we received during this inquiry.
Trends in problems with research integrity
14. Universities UK told us that “data and evidence on the scope and prevalence of 
research misconduct is limited”, and urged caution in attempting to assess the extent 
of the research integrity ‘problem’. Similarly, Professor Bishop said that “we have a very 
poor idea of how much [misconduct] is actually going on” and that “it is all very indirect 
evidence”.24 The available data comes from five sources, which are discussed below:
• surveys of researchers (i.e. self-reporting or describing the behaviour of others);
• data on journal article retractions;
• academic studies in the field of ‘meta-research’, such as of image retractions;
• studies of issues with ‘reproducibility’; and
• annual research integrity statements from research institutions, where available.
Survey data
15. The written evidence we received frequently cited a 2009 meta-analysis of international 
surveys as an insight into the prevalence of research misconduct. This analysis found that 
globally about 2% of scientists had falsified data at least once in their career, with around a 
20 Dr Ben Goldacre (RIN0073)
21 Universities UK, The Concordat to Support Research Integrity (July 2012), p17
22 Q15 [Professor Dame Ottoline Leyser]
23 Science and Technology Committee, Third Report of Session 2013–14, Clinical trials, HC 104
24 Q26
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third admitting to other questionable research practices.25 The main survey-based insight 
into UK research integrity comes from work by the Nuffield Council on Bioethics in 2014. 
UK researchers were asked about the temptations or pressures to compromise research 
integrity and standards, rather than the extent to which these occurred. Nevertheless, 58% 
of respondents reported that they were aware of scientists feeling tempted to compromise 
on research integrity, with 26% themselves feeling tempted or under pressure.26
16. Earlier this year, a survey conducted by the journal Nature found that, of the 2,632 
‘non-PI’ researchers responding (i.e. those who are not the ‘principal investigator’ for 
a research project), just 43% felt that their research group ‘never’ or ‘rarely’ condones 
research practices that ‘cut corners’, such as valuing speed over quality, or fundability 
over accuracy.27 The survey also identified a small subgroup of 376 non-PI researchers 
(one in seven) who were consistently negative about their lab culture, 70% of whom said 
that in the previous 12 months they had ‘often’ or ‘occasionally’ felt pressured to produce 
a particular result.28
Retractions
17. Problems with research can lead to a journal article being retracted (see Chapter 5), 
and the rate at which articles are retracted is increasing. A 2012 study of journal retractions 
around the world found that the number of retractions per year had increased by a factor of 
19 between 2001 and 2010. Even after adjusting for the growth in the published literature 
during the period, there had been an 11-fold increase in the retraction rate.29
18. We received many submissions which discussed how to interpret the increase 
in retractions. Retraction Watch, an American website documenting retractions and 
corrections, told us that the rise in retractions reflected several factors, including “a greater 
willingness of journals to withdraw problematic papers; a growing reliance on software 
tools to detect plagiarism; and more attention to manipulated or otherwise inappropriate 
images”.30 Similarly, a 2013 academic study of retractions concluded that:
The rising number of retractions is most likely to be caused by a growing 
propensity to retract flawed and fraudulent papers, and there is little evidence 
of an increase in the prevalence of misconduct. Statistics on retractions and 
findings of misconduct are best used to make inferences about weaknesses 
in the system of scientific self-correction.31
19. Some of our witnesses suggested that an increase in journal article retractions 
should be seen as a positive indicator of increased detection of problems,32 and noted 
that the reasons for retracting a paper included honest error.33 As Dr Elizabeth Moylan, 
representing the Committee on Publication Ethics, put it:
25 Fanelli, D., “How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey 
data”, PLoS One, 29 May 2009
26 Nuffield Council on Bioethics, The Culture of Scientific Research in the UK (December 2014)
27 Richard Van Noorden, “Some hard numbers on science’s leadership problem”, Nature, 557, 294–296 (2018)
28 Richard Van Noorden, “Some hard numbers on science’s leadership problem”, Nature, 557, 294–296 (2018)
29 Grienesen, M.L. and Zhang, M. “A Comprehensive Survey of Retracted Articles from the Scholarly Literature”, 
PLoS One, October 2012
30 Retraction Watch and The Center For Scientific Integrity (RIN0075)
31 Fanelli, D., “Why Growing Retractions are (Mostly) a Good Sign”, PLoS Medicine, 2013
32 Qq50–52 [Dr Wager]
33 Universities UK (RIN0057) para 25
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If something has gone wrong with the experiment, or, oops, the sampling 
was wrong and not quite what somebody anticipated, the publisher has a 
duty of care to make that correction or retraction as they see fit. It is not 
necessarily all bad. The way research operates is inherently messy; mistakes 
happen. We have to be comfortable with that. We are all human. How we 
fix it and make that transparent is the key.34
20. Nevertheless, Retraction Watch noted that “we cannot rule out the possibility that 
scientists are more willing to commit misconduct”. Dr Ivan Oransky, co-founder of 
Retraction Watch, told us that around half of retractions were due to misconduct, and 
that there had been around 400 journal article retractions in the UK since 1977.35 He told 
us that the retraction rate was “doubling every few years”, but that this was also the case 
globally.36 Retraction Watch calculated that in the UK there were 0.75 retractions per 
billion US dollars spent on research, compared with 0.44/$bn globally.37 This suggests that 
retractions are a rare event in the context of research spending. The higher UK rate could 
reflect a lower cost of research programmes or a higher number of papers per grant rather 
than a higher propensity for retractions.
Meta-research and image manipulation
21. A 2016 study of ‘image manipulation’ in journal articles in the fields of microbiology 
and immunology, cancer biology, and general biology revealed an increasing trend in this 
practice. Researchers reviewed over 20,000 biomedical research papers published in 40 
scientific journals from 1995 to 2014 and found that “3.8% of published papers contained 
problematic figures, with at least half [of those] exhibiting features suggestive of deliberate 
manipulation”. The study also found that “the prevalence of papers with problematic 
images has risen markedly during the past decade”.38
22. We asked Damian Pattinson, of Research Square, about what this might mean in the 
context of research integrity. He explained that altering an image was a common practice, 
which could be done for legitimate reasons, but that this needed to be made clear in the 
research paper:
Authors tend to touch up images fairly frequently. It is very rarely deliberate 
misconduct, but the rate at which figures are tweaked a little bit to make 
them look nicer is remarkably high. […] The vast majority of it is just 
adjusting the contrast a bit to try to make something a bit clearer. […] If you 
are looking at a field of cells and the pieces you are interested in are at the far 
sides of the picture, you might try to condense the middle, for example. It is 
not deliberately misleading, but […] if you have chopped out the middle, for 
example, you do not know whether that middle had something they wanted 
to hide, or whether it was just a blank space they wanted to cover up. […] As 
34 Q257
35 Q280
36 Q280
37 Q280
38 Bik EM, Casadevall A, Fang FC., “The prevalence of inappropriate image duplication in biomedical research 
publications”, mBio (2016)
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long as you say what you have done in any kind of manipulation you have 
performed, it is reasonable. General practice now is that you either make 
it clear with a line or you state in your legend exactly what has happened.39
Reproducibility and replication
23. The ability to recreate research findings could provide some indication of the 
reliability of the research. A submission from the medical journal the BMJ outlined the 
difference between ‘replication’ and ‘reproducibility’ in this context:
Replication—where multiple investigators aim to yield the same 
findings using independent data, analytical methods, laboratories, and 
instruments—does remain the gold standard in laboratory and other non-
human research […] Reproducibility means that independent investigators 
do not try to rerun a whole study, but they subject the original data to their 
own analyses and interpretations. This can verify the published findings 
but can also—crucially—extend and add to them through new research, 
hence making the most of the money and effort that researchers, clinicians, 
patients, funders, and the public put into the original study.40
The journal also explained that the extent to which replication was possible varied by 
discipline and research methods:
In clinical and public health research, replication is often impossible and 
the best we can hope for is that research is reproducible. […] In principle, 
replication is also desirable in epidemiological studies (such as large 
population-based observational studies) particularly when they affect 
health policy or regulators’ decisions about drugs and other treatments. 
But the long term, complex, and extensive nature of such research means 
that replication would all too often require many years and considerable 
new funding. For studies with patients and populations reproducibility is a 
much more attainable and affordable standard.41
24. According to a 2016 survey conducted by the journal Nature, more than 70% of 
researchers have tried and failed to reproduce another scientist’s experiments, and 52% of 
researchers believe that there is “a significant reproducibility crisis”.42 On the other hand, 
“less than 31% think that failure to reproduce published results means that the result is 
probably wrong, and most say that they still trust the published literature”.43
25. Our witnesses had a range of views on how to interpret the reproducibility ‘crisis’ in 
the context of research integrity. Professor Lewandowksy and Professor Bishop explained 
that “irreproducible research may reflect a lack of integrity of researchers, for example 
through manipulation or invention of data to achieve a particular result, or cherry-
picking of results or literature analyses to hide unwanted or uninteresting results”, but 
39 Qq145–147
40 BMJ (RIN0081)
41 BMJ (RIN0081)
42 Monya Baker, “1,500 scientists lift the lid on reproducibility”, Nature, 2016
43 Monya Baker, “1,500 scientists lift the lid on reproducibility”, Nature, 2016
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that irreproducible results may also be produced by honest researchers “because they 
are poorly trained or are using methods that they do not fully understand”.44 Catriona 
Fennell, representing the Publishers Association, advised that
It is important to make a distinction between reproducibility to some extent 
and research integrity; it would be damaging if there was a perception that, 
because your work could not be replicated, you did something unethical. 
That could be the case for a very small percentage, but normally it is not. It 
could be for another reason outside your control; it could be an antibody 
that was not as stable as you would like. Some of it could be very much 
improved with education and more focus on transparent methodology.45
We return to the issue of reproducibility in Chapter 4, in the context of ensuring research 
methods are adequately described in order to assist researchers looking to reproduce the 
same results.
Information from annual university narrative statements
26. One of the recommendations of the Concordat to Support Research Integrity is that 
employers of researchers should produce an annual statement on the number of misconduct 
investigations, although not all universities comply with this (see Chapter 3). We reviewed 
the available statements for 2015/16, along with other information provided in response to 
our survey of UUK members, and found that 51 universities undertook no investigations 
that year.46 This figure may reflect in part the fact that universities vary in size and in the 
volume of research activity they undertake. Reflecting what we were told about journal 
article retractions, Sheffield Hallam University suggested that “rises in allegations and 
cases of research misconduct are healthy signs of research communities that appreciate 
the importance of research integrity and that are beginning to police themselves”, and 
that “given human fallibility, universities and other research institutions where there are 
consistent nil returns are of more concern”.47 A lack of published information makes 
it difficult to assess exactly how many UUK members consistently report ‘nil returns’ 
over several years, although 20 universities told us that they had not undertaken any 
investigations since the Concordat was signed.
27. Dr Elizabeth Wager estimated that “most research institutions should expect at least 
one investigation every year, and those with many thousands of researchers should expect 
to perform several. Lack of investigations should not inspire confidence, but may indicate 
that institutions prefer not to address issues properly and would rather ignore them”.48 
Indeed, Dr Peter Wilmshurst, who himself has acted as a whistleblower in several cases, 
argued that “Universities and journals are […] as likely to admit the full magnitude of 
research misconduct as church leaders are to confess the extent of child abuse by priests”.49 
Similarly, James Parry, the Chief Executive of the UK Research Integrity Office (see 
Chapter 4), warned that:
44 Professor Stephan Lewandowsky and Professor Dorothy Bishop (RIN0046) paras 13–14
45 Q263
46 See Annex 1, and (RES0059)
47 Sheffield Hallam University (RIN0036) para 1
48 Dr Elizabeth Wager (RIN0014) para 2.3
49 Dr Peter Wilmshurst (RIN0091) para 6
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If an institution reported year after year that it never had any allegations, I 
would be somewhat sceptical about whether that figure was accurate. […] If 
the number is zero consistently, you may need to look at your practices and 
overall research culture.50
Dr Patrick Vallance, the Government’s Chief Scientific Adviser, agreed:
Would I be concerned if universities over a long period reported zero 
[investigations]? I think it would be odd. It is unusual to have nothing at 
all.51
28. The available data on misconduct investigations suggest that serious research 
misconduct is rare, but it is impossible to be certain without better data. There is a 
mismatch between the number of investigations and the scale of reported temptations 
to compromise on research standards, the ‘reproducibility crisis’ in some disciplines, 
the growth in journal article retraction rates, and trends in image manipulation. We 
hope that most researchers will never succumb to the temptations to compromise on 
research standards, and some of these trends may be the product of increased detection 
and correction of honest errors. Nevertheless, it is worrying that there seem to be so 
few formal research misconduct investigations conducted by universities. Increases 
in the number of investigations should be seen as a healthy sign of more active self-
regulation. Further work is needed to determine the scale of the problem.
50 Q396
51 Q635
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3 The Concordat to Support Research 
Integrity
Background
29. The Concordat to Support Research Integrity was developed by Universities UK 
(UUK) in 2012. The objective of the Concordat approach was to “work within existing 
systems and structure, and to provide a clear stimulus for concerted action” by articulating 
“a set of common expectations and commitments in a comprehensive and coherent 
national policy framework”.52 The Government’s response to our predecessor’s report 
in 2011 stated that, through the Concordat, “the Government will expect employers of 
researchers to deal with research integrity in an open and transparent manner”.53
30. The Concordat sets out five high-level commitments to research integrity:
(1) We are committed to maintaining the highest standards of rigour and integrity 
in all aspects of research.
(2) We are committed to ensuring that research is conducted according to appropriate 
ethical, legal and professional frameworks, obligations and standards.
(3) We are committed to supporting a research environment that is underpinned by 
a culture of integrity and based on good governance, best practice and support 
for the development of researchers.
(4) We are committed to using transparent, robust and fair processes to deal with 
allegations of research misconduct should they arise.
(5) We are committed to working together to strengthen the integrity of research 
and to reviewing progress regularly and openly.
Within each of these there are various recommendations on how to meet those high-
level commitments. The Concordat has eight formal signatories, including the research 
councils and funding councils, the Wellcome Trust, and UUK.
31. Almost all written submissions we received were positive about the Concordat as 
a concept. UUK advocated this approach over greater regulation, to avoid “presenting 
research integrity as an issue of compliance, rather than embedded through the lifecycle of 
research production and dissemination, and a cultural norm”.54 They also told us that the 
high-level nature of the Concordat ensured that the diversity of the sector was recognised, 
and that institutions could “implement its provisions in a manner appropriate to their 
specific context and strategic focus”.55
52 Universities UK (RIN0057) para 9
53 Science and Technology Committee, Tenth Special Report of Session 2010–12, Peer review in scientific 
publications: Government and Research Councils UK responses to the Committee’s Eighth Report of Session 
2010–12, HC 1535
54 Universities UK (RIN0057) para 16
55 Universities UK (RIN0057) paras 11–12
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Progress in implementing the Concordat
32. UUK published a Progress Report on the implementation of the Concordat in 
2016.56 They told us that “significant progress” had been made through the Concordat 
“in delivering greater coordination between the critical partners in supporting research 
integrity”.57 However, the Progress Report also suggested that there was still some way to 
go in ensuring that all UUK members fulfil its recommendations.
33. We wrote to all 136 UUK members in November 2017 to seek up-to-date figures 
on compliance. We asked them to confirm whether they fulfil three of the more specific 
recommendations of the Concordat:
• Identify “a senior member of staff to oversee research integrity and to act as first 
point of contact for anyone wanting more information on matters of research 
integrity”;
• Provide “a named point of contact or recognise an appropriate third party to act 
as confidential liaison for whistleblowers or any other person wishing to raise 
concerns about the integrity of research being conducted under their auspices”; 
and
• Publish a short annual statement on research integrity, incorporating:
Ȥ “a summary of actions and activities that have been undertaken to support 
and strengthen understanding and application of research integrity issues 
(for example postgraduate and researcher training, or process reviews)”
Ȥ “a high-level statement on any formal investigations of research misconduct 
that have been undertaken”.
The results of our survey are presented in Annex A, with the full individual responses 
available online.58 We were pleased to find that, in virtually all cases, universities could 
point to an individual with responsibility for research integrity and a whistleblowing 
contact. We did not attempt to assess whether this information was also easily available 
online for others to access, but we hope that our decision to publish the information we 
received will prompt UUK members to check that this is the case.
34. However, there was significant variation on the publication of an annual statement:
• 58% of Universities UK members published an annual narrative statement on 
research integrity, and were able to provide us with a link to either a 2015/16 
statement or 2016/17 statement, or both.
• A further 17% indicated an intention to publish their first annual statement 
shortly. Indeed, several cited our survey as a prompt to do so, including Bangor 
University, University of Greenwich, and others.
• 25% did not currently publish an annual statement and did not indicate an 
intention to do so in the future.
56 Universities UK, The Concordat to Support Research Integrity: A Progress Report (November 2016)
57 Universities UK (RIN0057)
58 Collated responses from UUK members regarding Concordat compliance (RES0059)
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Of those UUK members that did not publish an annual statement, the majority told us 
that this was because there had been no investigations to report since the Concordat was 
signed—although many other universities did publish explicit nil returns.
35. A handful of institutions cited concerns about confidentiality as being a barrier to 
them publishing an annual narrative report, or suggested that doing so would cause image 
problems for the university. For example:
• The University of South Wales told us that it does not publish information 
on instances of research misconduct, since “there are confidentiality issues 
embedded within such a disclosure that should be protected.”59
• The University of Bedfordshire claimed that it “adheres to the principles of 
the Concordat”, but that to publish information it would “need to consider the 
legitimate interests of a range of parties” and “bear in mind that in such cases 
the preservation of individual and contractual confidential [sic] would be among 
our considerations”.60
• Middlesex University told us that it does not routinely report investigations 
publicly because public disclosure is not appropriate in all cases, and “certainly 
not for cases where a formal investigation may have been instigated but where 
the individual concerned was completely exonerated”. The University claimed 
that it was “fully signed up to the Concordat”, but that it had “chosen not to 
separate research integrity, and research ethics in general, for special treatment”, 
since “to single out research integrity/ethics could, we believe, run the risk of it 
being perceived as being more important than other equally significant matters 
(e.g. misconduct in relation to our equality and diversity agenda).”61
• Birkbeck University told us that it was “more challenging to implement” the 
annual statement than other aspects of the Concordat. The University explained 
that “This is in part due to our small size—i.e. we rarely receive either formal 
or informal allegations of research misconduct, and so would be reporting 
on at most one (or, very occasionally, two) case(s) per year based on current 
levels. This obviously presents us with challenges both in terms of protecting the 
identities of those involved and with how to represent the information in a way 
that doesn’t over-inflate the scale of the problem.”62
36. The significance of universities failing to produce an annual report on research 
integrity was emphasised several times during our inquiry. Dr Elizabeth Wager told us 
that “secrecy surrounding investigations perpetuates the myth that major institutions 
are somehow immune from misconduct”, and that “annual accounts of the number of 
investigations and their outcomes will increase transparency and therefore trust in our 
institutions”.63 Research Councils UK (now defunct following the formal creation of UK 
Research and Innovation in April 2018) told us that there was “strong awareness” of the 
Concordat among “senior leaders, research managers and administrators responsible for 
59 Collated responses from UUK members regarding Concordat compliance (RES0059)
60 Collated responses from UUK members regarding Concordat compliance (RES0059)
61 Collated responses from UUK members regarding Concordat compliance (RES0059)
62 Collated responses from UUK members regarding Concordat compliance (RES0059)
63 Dr Elizabeth Wager (RIN0014) para 3.4
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implementation at institutions”.64 Nevertheless, the Vice-Chancellor at Regent’s University 
London replied that “ I must admit that I had not heard of the Concordat and it had not 
been brought to my attention. This may be because Regent’s did not gain University title 
until 2013 and was not admitted to Universities UK membership until 2014”.65
37. We asked Sir Ian Diamond, representing UUK, whether progress with implementing 
the Concordat had been rapid enough under UUK’s leadership. He told us:
I am very clear that there is a really rapid change in awareness and 
importance. Is it fast enough and are we there yet? No.66
However, he also told us that Universities UK itself does not have a role in requiring 
universities to comply,67 and that “universities are autonomous institutions”.68 When we 
put it to him that leadership was required to drive implementation, he told us that UUK 
was showing leadership and was “asking people to do things”.69 UUK subsequently wrote 
to us to set out the steps it was now taking in response to the issues raised by the inquiry, 
including plans to convene a Research Integrity Forum meeting in 2018 where issues 
relating to the Concordat can be discussed with the eight signatories.70
38. We asked Sir Mark Walport whether seeking 100% compliance with the Concordat 
was a reasonable aim. He argued that institutions that carry out the majority of publicly-
funded research were already complying, and that those that publish annual statements 
account for over 80% of public funding for research:71
It is important to recognise that some institutions have a very small amount 
of research activity. The really important issue is to make sure that those 
institutions that are doing significant amounts of research are reporting. 
All the evidence is that they are. […] There is room for improvement; I do 
not think anyone argues with that.72
We were encouraged by the Science Minister’s more robust response on the question of 
current compliance levels:
I do not think [compliance] is good enough, and UKRI should be using its 
lever of funding to get more institutions to comply. We should be aiming 
for 100% where it is public funding, and I take that extremely seriously. 
My personal expectation of every vice-chancellor is that there should be 
100% compliance […] it is not enough for any university in receipt of public 
funding just to have a web page.73
39. Most universities take their research integrity responsibilities seriously, but 
progress in implementing the Concordat to Support Research Integrity across the 
whole sector is disappointing. Six years on from the signing of the Concordat, the 
64 Research Councils UK (RIN0038)
65 Collated responses from UUK members regarding Concordat compliance (RES0059)
66 Q63
67 Q100
68 Q98
69 Q99
70 Universities UK (RES0020)
71 Q545
72 Q547
73 Qq618–619
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sector as a whole still falls some way short of full compliance in terms of publishing 
an annual statement, which risks giving the impression of pockets of complacency. We 
were surprised by the reasons that some universities gave for not publishing an annual 
statement on research integrity as recommended by the Concordat. The majority 
of universities have successfully balanced transparency against confidentiality in 
producing an annual statement, but a few are lagging behind and see transparency as a 
threat to their public image. Publishing an annual statement is a positive opportunity 
for an institution to set out the steps that it is taking to safeguard research standards, 
as well as to report on the number of investigations. We were encouraged that 
our letter to all Universities UK members prompted some of them to take steps to 
improve their compliance with the Concordat. More leadership is required to drive 
the implementation of the Concordat across the whole of the research sector, and we 
return to this issue in Chapter 6. We welcome Universities UK’s plans to convene a 
Research Integrity Forum meeting to consider our recommendations relating to the 
Concordat and look forward to seeing the results of their work.
Monitoring and incentivising compliance
40. In 2013, compliance with the Concordat became a prerequisite for receiving research 
funds from the higher education funding councils74 and UK research councils. Witnesses 
cited this as an important contributor to the success of the Concordat.75
41. Research councils and funding councils have operated separate processes for 
monitoring Concordat compliance. The Higher Education Funding Council for England 
(HEFCE, now superseded by Research England) described how compliance had improved 
among the institutions in England that it funds, from 25% of institutions reporting in 
2013/14 that they were still ‘working towards’ compliance with the Concordat, decreasing 
to 1.6% by 2015/16. This claimed low level of non-compliance does not tally with our 
work on assessing annual reporting rates, and perhaps reflects the somewhat vague 
nature of tracking “compliance with Concordat” when it contains only recommendations 
rather than explicit measurable requirements. RCUK did not appear to be able to provide 
equivalent information for the wider group of UK institutions it funds. Dr Tony Peatfield of 
RCUK explained that the research councils’ monitoring process was through ‘dipsticking’ 
a selection of institutions each year, and so could not provide comprehensive compliance 
figures.76
42. According to UUK, the research and funding council requirements mean that 
“institutions can face sanctions should they be shown to be failing to meet the commitments, 
providing a robust mechanism to ensure its adoption and implementation”. However, 
evidence from the Higher Education Funding Council for England (HEFCE, now replaced 
by Research England) and Research Councils UK revealed that such sanctions have never 
been deployed, despite the shortcomings in compliance we identified. HEFCE told us that:
In last year’s funding return we had two institutions [in England] that were 
not compliant […] we favour carrots, rather than sticks. That triggered a 
process with those institutions that involved very close contact with them, 
the requirement to develop an action plan and following up that action 
74 HEFCE, ‘Compliance with the Concordat to support research integrity’, Circular Letter 21/2013
75 Universities UK (RIN0057)
76 Q440
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plan. I am pleased to say that in this year’s return both those institutions 
are now compliant. This year we have two different institutions that are not 
compliant.77
Dr Peatfield told us that, where cases of non-compliance are identified, the research councils 
also “much prefer carrots to sticks” and “tend to try to work with the institutions”.78 The 
research councils have also not prevented any organisations from applying for funding. Dr 
Peatfield explained that imposing sanctions after funding has been provided is ineffective 
for project-based funding since “often by the time that a case [of misconduct] is proven 
the research grant will have ended, so withdrawing that funding is not feasible”.79 Dr 
Steven Hill, representing HEFCE, noted that the creation of UK Research and Innovation 
in April this year—bringing together the seven research councils with Research England 
and Innovate UK—created some opportunities for better alignment of research council 
and funding council assurance processes in the future.80
43. Compliance with the Concordat has technically been a condition of receiving 
funding from research councils and higher education funding councils since 2013, but 
meaningful sanctions have never been deployed. The Concordat contains mainly high-
level statements rather than explicit measurable requirements, and comprehensive 
information on ‘compliance’ is not collected by the funders. We recommend that 
the signatories update and strengthen the Concordat by making the requirements 
and expectations clearer, and produce a route map and timetable for reaching 100% 
compliance with the strengthened version within the next year. UKRI should collect 
and publish details of universities that are not compliant. In particular, the Concordat 
should be strengthened in relation to training on research integrity (discussed in Chapter 
4), processes for responding to allegations of misconduct (see Chapter 5), commitments 
to clinical trials transparency (which we will return to in a dedicated report) and 
publication of ‘negative’ research results.
Research integrity in Government departments
44. The Science Minister told us that “the standards for research funded and undertaken 
by Government departments is the responsibility of departmental Chief Scientific Advisors, 
with oversight provided by the Government Chief Scientific Advisor [GCSA]”.81 We wrote 
to each of the Government’s departmental Chief Scientific Advisors (CSAs) in December 
2017 to ask about responsibility for research integrity within their department and the 
processes followed when issues are identified in relation to research work undertaken or 
commissioned by the departments.82 We were pleased to hear that Dr Patrick Vallance, 
the new GCSA, expected all departments to have a CSA,83 and that the Department for 
Digital, Culture, Media and Sport was appointing a CSA.84
77 Q450
78 Q450
79 Q450
80 Q442
81 Letter from Sam Gyimah MP to Rt Hon Norman Lamb MP, February 2018
82 Individual responses from the CSAs are published as (RES0048)
83 Q640
84 Collated responses from Government Chief Scientific Advisors regarding research integrity (RES0048)
 Research integrity 22
45. Dr Vallance’s view was that “Departments should sign up to the Concordat, that the 
chief scientific advisers in the Departments should lead that process and that we should 
aim for a somewhat more consistent approach to how we think about research integrity”.85 
We were pleased to learn that he had written to all CSAs on this point, prompted by our 
inquiry.86
46. We endorse the Government Chief Scientific Adviser’s call for Government 
departments to sign up to the Concordat on Research Integrity to ensure consistency 
of approaches to research governance. If the Concordat is suitably strengthened, as 
we recommend above, this will be a useful step forward. We look forward to receiving 
further details of actions taken by the departments in response to his initiative in the 
Government’s response to this report.
85 Q637
86 Q642
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4 Supporting and promoting the 
integrity of research
UKRIO’s role in supporting research integrity
47. The UK Research Integrity Office (UKRIO, established in 2006) is an advisory body 
for the research sector on matters relating to research integrity. It does not investigate 
misconduct, but instead offers “support to the public, researchers and organisations 
to further good practice in academic, scientific and medical research”, and welcomes 
enquiries on “any issues relating to the conduct of research, whether promoting good 
research practice, seeking help with a particular research project or investigating cases of 
alleged fraud and misconduct”.87 UKRIO’s aim is to “provide practical and proportionate 
advice, which the public and the research community may find useful”.88
48. UKRIO is funded by institutional subscriptions, of £2,600 per year.89 The UKRIO 
website lists 80 such subscribers, of which 65 are Universities UK members. It therefore 
appears that at least 71 universities—i.e. the majority of the 136 UUK members—are 
not UKRIO subscribers.90 Other subscribers listed include universities outside the UK 
(including Belgium) and various UK academies and institutes such as the Royal Society 
and the British Academy.
49. James Parry (CEO, UKRIO) argued that the organisation’s reliance on funding 
from universities themselves (the majority of subscribers) did not represent a conflict of 
interest, since “pretty much everyone pays a flat-rate subscription, we are not beholden 
to any one institution. If a university says, ‘We don’t like the way you are handling this 
particular case,’ we can simply say, ‘That is all very well and good. We are happy for you 
to unsubscribe’”.91
50. It is surprising that most UK universities are not subscribers to the UK Research 
Integrity Office. The result is that the profile and impact of UKRIO might be highest 
with the institutions which already choose to participate, rather than the ones that 
might need the most help. The default assumption for all universities should be that 
they are subscribers to UKRIO, unless they can explain why they do not need to use 
UKRIO’s advisory services. We recommend that the Government and Universities UK 
write jointly to all universities to encourage them to engage with UKRIO and consider 
subscribing to its services.
Creating a suitable ‘research culture’
51. Many of the submissions we received argued that there was a need to consider the 
incentives and pressures acting on researchers, and to investigate how ‘research culture’ 
could be changed to better support research integrity. Professor Marcus MunafÒ argued 
that:
87 UKRIO, Position statement: Statutory regulation of research integrity (November 2016), para 5
88 UKRIO, Position statement: Statutory regulation of research integrity (November 2016), para 7
89 Q364
90 UKRIO, ‘List of UKRIO Subscribers’, (accessed 6 June 2018)
91 Q367
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Research integrity is the wrong focus, or at least only represents a small part 
of a much larger problem. That problem is the wider incentive structures 
that exist across science (or at least some scientific disciplines). […] Rather 
than focus on the rare cases of outright scientific fraud, we should address 
the more insidious systemic problems that impact on the wider scientific 
endeavour.
52. A 2014 report on the ‘culture’ of research produced by the Nuffield Council on 
Bioethics92 pointed to a broad set of factors as contributors to problems with research 
integrity:
• High levels of competition when applying for jobs, promotion, funding;
• Short-term funding leading to a decrease in the time available to plan research, 
ambitious timescales;
• Assessment of research—pressure to publish in high-impact journals, and 
‘publish or perish’; and
• Career progression and workload—a culture of short-termism and high-stress.
Professor Dame Ottoline Leyser, representing the Nuffield Council on Bioethics, 
complained that research is “hyper-competitive and the rules for winning the competition 
are the wrong rules”.93 She argued that this meant that “at some level we have lost sight of 
what science actually is”:
Science is a method. It is a way of building models of the world that have 
both explanatory and predictive power. It is not about the ultimate quest 
for “Truth”. It is not about correct and incorrect; it is a progressive method 
for proposing, testing and rejecting or refining models of the world […] 
It moves forward extensively by being wrong […] The way things have 
gone in the research system, we have developed a culture where people are 
rewarded for being “right” and being “exciting” in some way. Those things 
have nothing to do with science.94
53. We were also told that the competitive research environment is off-putting for some 
people. Professor Bishop suggested that “sometimes the people we most want to keep in 
science, and who want to do the careful stuff, get so demoralised that they leave, and we are 
left with the people who think, ‘Oh well, I’ll tweak it because my boss says I should tweak 
it’”.95 Professor Lewandowsky and Professor Bishop argued that “most scientists start out 
motivated by pursuit of knowledge, but they can become demoralized if they see rewards 
going to those who adopt dubious practices to get ahead”.96 They called for institutions 
and funders to adopt “criteria that reward researchers for reproducible research rather 
than showy research, with a focus on quality rather than quantity”.97
92 Nuffield Council on Bioethics, The Culture of Scientific Research in the UK (December 2014)
93 Q15
94 Q6
95 Q34
96 Professor Stephan Lewandowsky and Professor Dorothy Bishop (RIN0046) para 19
97 Professor Stephan Lewandowsky and Professor Dorothy Bishop (RIN0046) para 19
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54. The Royal Society suggested that a range of incentives within the system can work 
against research integrity:
labs that take extra time to verify their data might have fewer publications 
to show their funders, those scientists who decide against splitting their 
data to get multiple publications have fewer publications to enter into the 
[Research Excellence Framework]. There is no single aspect of the culture of 
research that could be changed to fix this, it is the cumulative effect of lots 
of different mechanisms and pressures.98
They argued that “systems of publishing, assessment and dissemination of work should 
be adjusted in order to incentivise ‘good behaviour’”.99 The Society is currently holding 
a series of workshops on research culture, creating what they describe as a “national and 
self-sustaining conversation” about how to embed a culture of research that maintains 
research excellence.100
55. We received some evidence that the pressures on researchers vary according to the 
way in which the institution is funded. The Director of the MRC Laboratory of Molecular 
Biology—a research council-funded institute rather than a university—told us that a 
healthy research culture “may be easier to achieve” in a research institute than in some 
university environments:
Freed from other responsibilities, the emphasis of our scientists is on their 
research output, and this determines their reputation and reward. With 
relatively secure funding, we take a long-term view, and a track record of 
persistently getting discoveries right is highly valued. Emphasis on the short 
term and on numbers of publications per se is not helpful. Core funding (of 
the entire institute) is decided by reviews every five years, and collective 
success is important as well as individual achievement. This creates peer 
pressure for everyone to do well, and colleagues do not hesitate to be critical 
of work perceived as shoddy. Funding of larger entities, in addition to grants 
to single groups, can help to create this culture. The ability to provide core 
resources to bridge gaps (e.g. between externally-funded grants) relieves 
some of the short-term pressure to publish, and allows the emphasis to be on 
quality even if it takes longer. Universities, and their funding mechanisms, 
should ideally do the same.101
56. One factor that is frequently cited as a determinant of institutional and researcher 
behaviour is the Research Excellence Framework (REF)—the periodic review of the quality 
of research undertaken which is used to determine the ‘quality-related’ funding that 
institutions receive from higher education funding councils.102 Professors Lewandowksy 
and Bishop argued that the influence of the REF presented an opportunity for tackling 
perverse incentives on researchers.103 They suggested that the ‘environment’ section of 
the REF should “include information on responsible public communication of science, 
98 The Royal Society (RIN0049) para 5
99 The Royal Society (RIN0049) para 7
100 The Royal Society (RES0014)
101 Director, MRC Laboratory of Molecular Biology (RIN0095) paras 3.1–3.4
102 For further information on QR funding and the dual support system see Higher Education Funding in England, 
Commons Briefing Paper CBP 7973, January 2018
103 Professor Stephan Lewandowsky and Professor Dorothy Bishop (RIN0046) para 19
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to discourage press offices from overhyping research”. HEFCE told us that the 2014 REF 
exercise did include some assessment of research integrity as part of the assessment of 
the research environment, albeit only for medical and life sciences and social sciences.104 
We were encouraged to hear that in the 2021 REF process, all assessment panels will be 
required to consider how research integrity and misconduct issues can be covered in the 
research environment section.105
57. Creating a healthy ‘research culture’ is just as important as tackling lapses in 
research integrity, and would help ensure that a career in research is attractive to those 
who value rigour, accuracy, honest and transparency. We endorse Research England’s 
plans to require the REF 2021 assessors to consider how research integrity issues can 
be taken into account. We hope that this will underline the importance of research 
integrity to a healthy research environment, and counterbalance some of the pressures 
to compromise on integrity. For this to be successful it must be implemented in a way 
that encourages universities to be more transparent about research integrity and 
investigations, rather than an additional incentive to avoid drawing attention to lapses 
in integrity.
58. There is a need to understand more fully the effects of the current funding system 
on researcher and institutional behaviour, and consider how unwanted effects can be 
minimised. We recommend that UKRI commission research to understand the effects of 
incentives in the research system on researcher behaviour and assess where adjustments 
or counterbalances may be needed to support research integrity.
Training
59. Sheffield Hallam University highlighted the importance of training to its approach 
to research integrity:
Educational initiatives are key both for academics, researchers, doctoral 
students, relevant support staff and students on taught courses. Ensuring 
that research ethics and integrity are mandatory core elements of all the 
taught research methods curricula ensures that future generations of 
researchers are properly informed and that due attention to these issues is 
given in all research undertaken on taught courses.106
They told us that training on ethics and integrity is mandatory for doctoral students at the 
university and is included in the research supervisor training programme. They explained 
that:
The aim is to assure research integrity by making staff aware that there 
is a collective responsibility to report any apparent breaches as negative 
publicity related to research misconduct by any research in the university 
will impact on all researchers’ work. Thus it becomes research misconduct 
to collude with and/or fail to report any apparent breaches of policy and 
procedures.107
104 Q471 [Dr Hill]
105 Q472 [Dr Hill]
106 Sheffield Hallam University (RIN0036) para 3
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60. The risks of failing to ensure that training in research design was provided to research 
supervisors was made clear by Dr Alyson Fox from the Wellcome Trust:
The basic fundamentals of designing an experiment and research programme 
are really hard. Traditionally, but not exclusively, a young researcher coming 
into a lab to start a PhD, or their first postdoc, is taught by the person above 
them, so it is generally not even the [Principal Investigator]—the lab head; 
it is the postdoc or senior postdoc. In bad cases, essentially it is the blind 
leading the blind.108
A similar point was made by James Parry, UKRIO’s Chief Executive:
The question is, are we teaching researchers what they need to know, or are 
they picking things up as they go along? If it is the latter, are the picking up 
good habits or bad?”109
61. Provision of training is referred to in the Concordat to Support Research Integrity, 
albeit only in general terms. Signatories commit to “supporting a research environment 
that is underpinned by a culture of integrity” by providing “suitable learning, training and 
mentoring opportunities to support the development of researchers”.110 Funders provide 
some further specification of what this should entail; the formal RCUK requirement in its 
‘Statement of Expectations for Postgraduate Training’ is that:
Students should receive training in the principles of good research conduct 
in their discipline, and understand how to comply with relevant ethical, 
legal and professional frameworks. Students should be provided with 
training to identify and challenge unintentional bias as appropriate to their 
studies.
Students should receive training in experimental design and statistics 
appropriate to their disciplines and in the importance of ensuring research 
results are robust and reproducible.111
As with other aspects of the Concordat, compliance with this is in principle monitored by 
the research and funding councils. Again, Dr Tony Peatfield from RCUK told us that there 
is “a dipstick monitoring process”, but “obviously we cannot have comprehensive policing 
of what actually goes on. One of the things we have done is to try to focus our doctoral 
training in fewer places, and that makes for better training but also makes it easier to keep 
an eye on what is going on”.112
62. Rather than leave this training for the institutions themselves to design, the 
Association of Medical Research Charities suggested that there was a need for centralised 
training on matters relating to research integrity:
We would encourage Government to consider supporting a centralised 
training and education resource for researchers across the breadth of 
research disciplines. This could be led by UK Research and Innovation 
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and the National Institute for Health Research to support excellent science 
more broadly. It would be significantly easier to achieve from a ‘top down’ 
approach, rather than fragmented efforts from multiple smaller bodies. 
It could, for instance, form a significant part of a researcher’s training 
throughout their PhD thereby equipping future scientists with the skills 
required to create cultural change.113
63. Sir Bernard Silverman, representing UKRIO, told us that “some formal work on 
research integrity would be very worthwhile, just as university lecturers nowadays get 
formal training in teaching”.114 Dr Steven Hill, representing HEFCE, agreed that “there is 
probably a core of activity where consistent training would be helpful”,115 but both HEFCE 
and RCUK witnesses suggested that a range of providers could provide contextualisation 
for different disciplines.116
Statistical training
64. We explored with witnesses whether training was particularly needed in relation 
to statistics, given the need to understand the problems associated with ‘p-hacking’ 
and ‘HARKing’ (see Chapter 1, Box 1). Professor Bishop told us that “people are using 
statistics without fully understanding what they are doing. That is extremely dangerous. 
We need much better statistical training, and more statisticians to deal with this issue”.117 
She explained that “in some disciplines there are statisticians available for consultancy, 
particularly in medicine. In most disciplines, there are not”.118 Professor Leyser was 
concerned that “the statistical training people get is not in the principles of statistics; it is 
‘Here is a list of statistical tests and here is a programme that does it for you’. The training 
has to be about the principles and not the details”.119 She argued that “what they think 
they are doing is testing whether or not they are right; if their p-number is small, it means 
they are right, and if their p-number is big, it means they are wrong. That entire approach 
is deeply flawed and needs to be shifted right from the beginning in education”.120
65. Rather than training all researchers to the same level, Dr Arnaud Vaganay, a meta-
researcher, argued that research teams could include individuals with the relevant skills; 
he told us that “usually research teams are too homogenous. Economists work with 
economists; sociologists work with sociologists; and usually statisticians work with 
statisticians. Perhaps a solution to the problem would be to bring in people with different 
backgrounds”.121 Similarly, the Royal Statistical Society argued that “the UK’s system for 
research and science funding needs to support more skilled statistical instructors who 
work across disciplines. Mechanisms to address statistical integrity are most advanced for 
medicine and clinical trials, but models developed there should be applied more widely to 
other fields of research”.122
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66. We are encouraged to hear that some universities make training in research 
integrity a mandatory part of doctoral studies and include it in their research 
supervisor training programme. It is important that the attitudes to research integrity 
transmitted to the next generation of researchers are the right ones, and that those 
supervising them are also suitably trained. We recommend that UKRIO provide 
guidance to universities on best practice in delivering training to doctoral supervisors.
67. The research councils do not have reliable information on what training is 
currently being delivered. The increased concentration of training, through ‘Centres for 
Doctoral Training’, presents an opportunity for monitoring whether suitable training 
on research integrity is being provided as part of a PhD. We recommend that UKRI 
assess whether suitable training is being provided in line with current requirements 
and report back to us on its findings. UKRI should also consider further the case for 
centralised provision of training on research integrity, or standards that could be set.
68. We recommend that UKRI consider how best to encourage research teams to engage 
with statisticians as part of their research, and how best to improve the statistical 
competencies of researchers in general.
‘Open science’
69. The BMJ told us that “increasingly, journals have policies to enhance the reproducibility 
of published research by making the underlying ‘raw’ data accessible to other researchers”.123 
We heard that journals including Science, Nature, and the PLoS (Public Library of Science) 
require authors to make study protocols, datasets, and code available on publication,124 
and that the BMJ “requires authors of clinical trials to make anonymised individual 
patient data available on reasonable request”.125 Moreover, some journals are integrated 
with data repositories to facilitate data sharing.126 Universities UK agreed that open access 
to research outputs and data “will undoubtedly create opportunities for enhancing the 
integrity of research” and that this approach “may help to address the challenges associated 
with reproducibility and publication bias more effectively than a regulator could”.127 In 
particular, publication of datasets could assist with identifying errors.128
70. However, we also heard that open data can present risks to integrity through secondary 
misuse, and ‘p-hacking’ in particular (see Chapter 1, Box 1). As Professor Lewandowsky 
and Professor Bishop explained, “if one subdivides a large multivariate dataset in every 
possible way, some associations will be found by chance, but they cannot be regarded 
as meaningful unless adequate correction is made for the number of statistical tests”.129 
Professor Bishop provided us with an example of this from the USA:
A group of people who thought that vaccines caused autism—still, after all 
these years—found a big dataset from some American survey. They dived 
into it and found that if you looked at the children who were boys, who were 
black, who were of a particular age range and went to a particular nursery, 
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124 BMJ (RIN0081) para 3.a.v
125 BMJ (RIN0081) para 3.a.v
126 BMJ (RIN0081) para 3.a.v
127 Universities UK (RIN0057) para 29
128 Q23
129 Professor Stephan Lewandowsky and Professor Dorothy Bishop (RIN0046) para 26
 Research integrity 30
lo and behold there was an association between vaccination and autism. 
If you looked at the whole dataset, of course, there was nothing, That was 
classic p-hacking. The paper was published. It was subsequently retracted, 
but the damage was done. It is still thought to be a cover-up by the original 
researchers who did not publicise that amazing fact.130
The fact that the paper based on p-hacking was published in the first instance—even if 
subsequently retracted—demonstrates some of the limitations of peer review as a means 
of protecting against this practice.
71. Professor Bishop argued that there was a need for those wishing to re-analyse data 
to submit a protocol setting out the analysis that will be done, rather than “a free-for-all 
where you can just poke around and pull out the bit that happens to support your views”.131 
Dr Vallance also highlighted potential privacy issues relating to individual patient data, 
which also underlines the need for a process for applying for access to data. He highlighted 
the Clinical Studies Data Request132 as a case study of how this process could be managed, 
with applicants required to specify their research question and methods before accessing 
the data in order to minimise risk that secondary researchers will “data-trawl large 
datasets and come up with very bad post-hoc analysis”.133
72. The Royal Statistical Society effectively summarised the competing arguments for us:
In an ideal world, open access to data would allow external validation of any 
claim. But the downside of open access is its abrogation of the protections 
that prior approval and registration of study protocols affords, and could 
lead to ill-founded disputes in areas of contested science.134
Our predecessor Committee recommended in its report on Big Data that a ‘Council 
on Data Ethics’ should be established.135 More recently, in our report on algorithms 
in decision-making, we highlighted the newly-established “Centre for Data Ethics and 
Innovation”.136 There is a role for such a body addressing the issues we have explored here 
in the context of open data and research integrity.
Better reporting of methods
73. The BMJ noted that one of the drivers of problems with reproducibility (see Chapter 
1) was research methods being reported “too cursorily or without clarity”, and that “this 
may mean that the methods themselves were inadequate, or simply that they were badly 
written up, or both”.137
74. Catriona Fennell, representing the Publishers Association, argued that online 
publishing meant that there was less of an excuse not to provide full methodological 
details to ensure reproducibility:
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In the past, with print, if the author had a word limit, there was a risk that 
they would reduce the method section, and you basically ended up with 
somebody writing a recipe: “Throw some flour in a bowl. Add some butter 
and throw it in the oven for a while.” Actually, what you need is what type 
of flour and how many grams, what temperature should the oven be, what 
type of butter, and so on.138
We were directed to various initiatives to improve the reporting of research methods, 
including reporting guidelines and checklists such as those collected for health research 
by the EQUATOR network.139
75. We are encouraged to see moves towards open publishing of datasets, and steps 
being taken to improve reporting of research methods through reporting checklists. 
However, we also recognise the need for protocols for accessing research data to ensure 
that secondary analysis is conducted appropriately. The Centre for Data Ethics and 
Innovation should consider further how best to balance the need for data to be openly 
shared with the need to ensure that data is used responsibly in secondary analysis.
138 Q265
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5 Detecting and responding to 
problems with research integrity
Detection
76. In 2011 our predecessor Committee explored the extent to which the peer review 
process can reasonably be expected to identify misconduct. It concluded that “the integrity 
of the peer-review process can only ever be as robust as the integrity of the people involved. 
[…] Although peer review is not designed to systematically identify fraud or misconduct, 
it does, on occasion, identify suspicious cases”.140 In our current inquiry, Dr Wager told 
us that “conventional peer review done by journals does not involve scrutiny of raw data 
and so cannot be expected to detect most cases of fabrication or falsification”.141 Similarly, 
Professor Leyser believed that peer review “is never going to be very good at picking up 
fraud […] It is not the job of the system to spot fabrication”.142
77. Our predecessors concluded that “in addition to relying on the vigilance of the people 
involved in the process, publishers must continue to invest in new technology that helps to 
identify wrongdoings.” In 2012 the InterAcademy Council also recommended that journals 
should use technological means to protect the integrity of the research literature, noting 
that “an increasing number of journals are using software to guard against plagiarism and 
the inappropriate manipulation of figures”.143
78. The BMJ listed some of the techniques that journals use, including “statistical analysis 
of patterns in datasets, image checking tools, linguistic analysis, investigative journalism, 
post-publication peer review, and policies that require full reporting of methods and results 
(using reporting guidelines such as the CONSORT 2010 Statement for clinical trials), and 
data sharing”.144 They told us that “none of these approaches is perfect or foolproof but 
each has its merits and deserves further evaluation”.145
79. One example of using software to detect errors is ‘Statcheck’, a programme based 
on the statistical package ‘R’ which has been designed to automatically identify statistics 
used in journal articles and re-compute them independently to check for certain kinds 
of errors. Statcheck was initially used to assess what proportion of psychology journal 
papers that included a ‘null hypothesis significance test’ contained a statistical error.146 
Half of the papers assessed by the programme were found to contain at least one problem, 
with one in eight papers containing “a grossly inconsistent p-value that may have affected 
the statistical conclusion”.147 Later, Statcheck was used to identify individual papers 
containing potential errors and automatically contact the authors.148 Professor David 
Hand, representing the Royal Statistical Society, told us that, while fraud was “particularly 
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pernicious”, more common problems with data were “oversights in pre-processing the 
data; ignoring missing values or inadequate ways of handling them; introducing errors 
when pre-processing the data, which happens quite often; and misunderstanding the 
statistical tools you are using”.149
80. Professor Hand told us that while StatCheck was capable of checking for a particular 
kind of problem, the range of potential problems was so broad that it would not be possible 
to entirely automate checking for errors with software.150 A move towards more datasets 
being available for secondary analysis by such statistical tools nevertheless presents a 
greater opportunity to use these techniques to check for potential problems, albeit with 
the caveats we explore in Chapter 4.
81. Other techniques we heard about during our inquiry included software for detecting 
image manipulation (see Chapter 1). Damian Pattinson told us that Research Square was 
working on software that can help with identifying “pixellated areas”, with automation in 
the early stages of development.151 He told us that investing in manual checking of images 
for signs of manipulation was expensive, and said that
Some publishers I work with question whether it is cost-effective to spend 
that money. An outlay of between $20 and $30 [per paper for scrutiny of 
images] is significant when it is not quite clear what the repercussion is. […] 
A journal may have to retract a paper that has clear problems with images, 
but that is about as bad as it gets for them. Journals often feel that that is not 
enough of a threat to them to require a million-dollar investment in fixing 
the problem.152
82. There is a continuing need for publishers to invest in techniques and technologies 
to spot problems with research papers. While the purpose of peer review is not to 
detect fraud, the sector’s responsibility for the integrity of the research base includes 
taking reasonable steps to ensure that technology to detect problems is developed 
and put to good use. This may be an area in which market forces do not obviously 
support this investment of resource. A Concordat-style set of commitments in the 
academic publishing community to invest jointly in software for the detection of 
image manipulation—or common standards for checking images—may be required. 
We recommend that UKRIO convene a discussion with publishers to explore this.
Responding to problems with research integrity
Institutional processes for responding to misconduct allegations
83. The Concordat to Support Research Integrity explains that the primary responsibility 
for investigating allegations of misconduct rests with the employers of the researchers 
involved.153 It notes that employers of researchers should already, as a condition of the 
grants they receive, have “robust, transparent and fair processes for dealing with allegations 
of misconduct that reflect best practice”.154
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84. We were concerned by a perception in the submissions we received that institutions 
were in effect ‘policing themselves’ when responding to allegations,155 and asked witnesses 
about practice in relation to external input to the process. Professor Sir Ian Diamond, 
representing UUK, told us that he was “comfortable” with the process being undertaken 
by colleagues within the same organisation, although he would be “pretty uncomfortable 
if it was someone from the same laboratory or something like that […] I do not have a 
problem with someone being brought in from outside, but I do not think the way the 
system is at the moment is broken”.156
85. UKRIO provides guidance to institutions on procedures for investigating misconduct 
allegations.157 These include a ‘screening’ stage as a precursor to the ‘investigation panel’; 
the guidance states that a Screening Panel should consist of at least three senior people, 
and that “It is desirable, but not essential, that one or more members of the Screening 
Panel be selected from outside the organisation, rather than members drawn from 
within the organisation. Allegations that involve senior staff and/or that are judged to be 
especially serious, complex or controversial may particularly benefit from the presence of 
someone external to the organisation on the Screening Panel”.158 However, if an allegation 
progresses to the investigation stage, “it is a requirement that one or more members of the 
Investigation Panel be selected from outside the organisation”.159
86. Wendy Appleby, the Concordat-recommended ‘named person’ responsible for 
research integrity at UCL, explained the processes followed, and the stages at which 
external panel members are sought:
Within our procedure, as named person, my responsibility is to oversee 
the operation of the procedure. I make judgments in the initial stages of 
the procedure and help to provide advice on its operation, but I do not 
make judgments on the latter stages. […] It is a three-stage process, which 
is standard in the [UKRIO] guideline procedure.
The initial stage of the process is a preliminary assessment, which is the 
stage I take. Effectively, it asks, “does the allegation of misconduct fit within 
the definition of research misconduct, or should it be dealt with under a 
different process—for example, financial problems or a staffing process?”.
If I decide that it fits within the definition, the next step is for it to go to 
screening. At UCL, we establish a screening panel, which is effectively a 
peer review. […] Typically, our screening panel is three individuals drawn 
from within UCL, but we are very careful to check that there is no conflict 
of interest with the research or the researcher where there is concern. 
[…] Screening is very much about saying, is there meat on the bones of 
the allegation? Is there prima facie evidence of research misconduct? The 
important thing to emphasise is that it is about an intention to deceive, 
because things can go wrong.
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[…] If it goes to the third stage, which is the research misconduct investigation 
panel, we establish a fresh panel of a minimum of three people, which will 
include an external member—I recall one panel where the membership was 
entirely external—and that panel will conduct an in-depth investigation.
[…] It is not all self-investigation; indeed, in our screening panel, our 
procedure allows us to use an external member if we wish. It might be that 
we are seeking a particular form of expertise; it might be a very complex 
case. If we wish to, we can do it at screening level as well.160
87. However, she suggested that the UKRIO guidance on screening panels might not be 
being followed at every institution:
I have noticed that in some universities’ procedures they still refer screening 
to the head of the department where the allegation sits, or a single person. 
There is greater danger for conflict of interest there, but panellists tend to 
operate in very independent ways, and use the process and their expertise in 
forming judgments. In an internal employment process, say a disciplinary, 
a grievance or something like that, typically an internal set of staff would 
be involved in hearing that.161
88. Universities and other employers of researchers need to be able to demonstrate 
that they are following best practice in the way that investigations are conducted. 
The annual narrative report recommended by the Concordat (see Chapter 3) is one 
opportunity for institutions to review their processes and set out whether they reflect 
UKRIO’s guidance. Any suggestion that best practices are not being followed is a 
concern, particularly given the reputational risk of, for example, not using external 
panel members in some stages of the process. UKRIO’s guidance on misconduct 
processes was published in 2008; it is worrying that, ten years on, some institutions 
may not yet have acted on it. We recommend that following best practice in use of 
external panel members form an explicit part of a strengthened Concordat.
Complex cases
89. We also received evidence on some of the additional steps that institutions take in 
complex and high-profile cases, going beyond the standard UKRIO model. Box 2 provides 
an example of this at UCL.
Box 2: The case of Paulo Macchiarini
In January 2016, Swedish Television broadcast a three-part documentary, 
Experimenten (The Experiments), exposing several examples of misconduct 
concerning transplantations performed by Paolo Macchiarini, a visiting professor at 
Karolinska Institutet (KI). During his tenure at KI, Macchiarini performed synthetic 
trachea transplantations in three patients at the Karolinska University Hospital. 
A Guardian article from September 2017 states that the documentary “argued 
convincingly that Macchiarini’s artificial windpipes were not the life-saving wonders 
we’d all been led to believe. On the contrary, they seemed to do more harm than 
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good—something that Macchiarini had for years concealed or downplayed in his 
scientific articles, press releases and interviews”.162 A written submission to us from 
two academics at the University of Liverpool explains that part of the misconduct lay 
in ‘over-hyping’ patient outcomes:
The Swedish Central Ethics Review Board has recently published its 
report on research misconduct relating to scientific articles authored by 
Macchiarini and co-workers, the conclusion being that a series of six papers 
should be retracted. A key problem identified in the report was that the 
scientific articles contained over-hyped descriptions of patient outcomes, 
which gave the impression that the health benefits of the synthetic tracheas 
were much greater than they actually were.163
Macchiarini was also a visiting professor at UCL until 2014, and a collaborator of 
UCL academics.164 Given Macchiarini’s connection to UCL and related research 
undertaken there, we asked Wendy Appleby (the university’s ‘named person’ for 
research integrity) to describe the “special inquiry” process that UCL followed to 
explore a range of allegations of misconduct in relation to regenerative medicine. She 
explained that “a number of allegations came in on the area of regenerative medicine 
research, focusing particularly on some of the sorts of methods Macchiarini was using, 
with slightly different angles in each allegation and lots of questions. One interesting 
thing about the way a research misconduct process works, or the stages within the 
overall procedure, is that it relies on allegation, a respondent and so forth. At UCL, 
we felt we had had a connection with Macchiarini, even though it was not current. 
We were doing research and working in the area and we had received a number of 
slightly different variants of misconduct allegations. We felt that we needed to step 
back from the approach where you need an allegation to look into a specific thing, 
and take a more generic approach, which was why we did the special inquiry, and that 
that should be independent. We had an entirely external panel for the special inquiry, 
with separate legal advisers we appointed and paid for, to help them in their work”.165
Wendy Appleby told us that the UCL Special Inquiry “made a number of very helpful 
recommendations; indeed some of them were around the operation of our overall 
research misconduct procedure, and you can see them. Some of them were around 
scientific practice, and working appropriately within the regulatory environment. 
There are lessons in terms of how we work with research councils, [including] 
balancing the interests of the individual and their rights and the expectations of 
funding councils, and the contract we have with them. Finally, within UCL itself, we 
are looking at the body of activity. It is a very wide-ranging area of research activity, 
and includes about 1,000 individuals, a huge number of staff across a wide range 
of organisational units. We were looking at whether we had the governance right, 
so that if ever there were a rogue action in the future we would have more robust 
oversight of it”.166
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Maintaining the integrity of the research record
90. Publishers have a key role to play in maintaining the integrity of the research record 
through retracting problematic articles. The British Medical Journal (BMJ) outlined the 
various steps that publishers can take when problems are detected:
For proven misconduct a journal may publish a correction or notice of 
concern about the article; retract the article; publish commentaries about 
the case; tighten its peer review, statistical review, and publishing policies; 
ban authors; and/or ask the authors’ institution (and any institutional 
review board or ethics committees involved that approved the research) to 
investigate.167
The Publishers Association added that:
Once a query about an article is received, journals will investigate and decide 
upon the appropriate action to take in accordance with the Committee on 
Publication Ethics guidelines. This process can be incredibly detailed and 
time intensive, but is crucial to the integrity of research and the reputation 
of the publisher of that research.168
91. Dr Elizabeth Moylan, representing the Committee on Publication Ethics, outlined 
some of the problems that publishers encounter when raising issues with an institution:
If an issue arises and is brought to a journal’s attention, perhaps on a 
published paper, in the first instance we go to the authors and ask for an 
explanation, and we loop in their institutions. That can be quite tricky 
sometimes, because some institutions can come down on people quite 
harshly, and some institutions might not respond. […] The publisher does 
not have the tools to do that investigation and the published article is, 
effectively, on hold until the investigation is completed.
That is where it is tricky, because publishers have a responsibility for the 
integrity of the published literature. What do they do in the interim? Often, 
people put an expression of concern on a published article or an editor’s 
note, because they are waiting for the outcome of an investigation that might 
determine whether the paper is corrected or retracted. […] The publisher is 
waiting for the institution to get back to them.169
92. Dr Trish Groves, the Director of Academic Outreach at the British Medical Journal 
(BMJ), told us that in her experience of 28 years at the BMJ, a university has never 
proactively contacted that journal regarding the outcome of a misconduct investigation 
to suggest that articles may need to be retracted, and that instead “we are often the ones 
banging on the door of the institution”.170 In contrast, she told us that journals talk to each 
other though, and that “if one journal retracts, it often contacts other journals”.171
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93. The BMJ suggested that publishing corrections to papers was not always an effective 
way to correct the record, since “the original, erroneous versions of papers that have 
subsequent published corrigenda are cited at roughly the same rate as the corrected 
versions”.172 Similarly, a recent article for Wired magazine notes that:
For every retracted paper, the original unmarked copy still lives on in 
print (where you might have read it in the first place). And if you have cited 
that paper in your own work, you don’t receive an alert that one of your 
citations has just imploded. Which means that you might be totally in the 
dark. […] One stem cell paper published in 2005 and retracted in 2010 has 
been cited 667 times — so far. Nearly half of those citations occurred after 
the retraction was made official. Here we are, in 2017, seven years after 
its retraction, and authors continue to refer to it as if nothing happened 
(including half a dozen times in the past couple of months alone). Nobody 
knows the extent to which the mistakes in that paper have affected any of 
those papers downstream.173
94. Dr Trish Groves, representing the BMJ, suggested that it was the responsibility of 
authors to ensure that they check the references they are citing:
We know anecdotally that a lot of people put references in their papers 
without actually reading the papers they cite in the reference list. They have 
not bothered to check at the journal website or in an index, such as PubMed 
or MEDLINE, that it has a big thing that says, “Look out. Retraction.” They 
do not check. That is initially the responsibility of authors. Some journals 
have systems where, when a paper is to be published, during the technical/
copy editing phase all the references are checked. At that point, a good copy 
editor ought to pick it up and say, “Hang on. This one’s been corrected,” 
and it should come back to the handling editor and the author, but I do not 
know how often that happens.174
Catriona Fennell added that there was a “lag” in authors adjusting to a paper having been 
retracted:
If a paper is retracted, papers may have already been written that cite it; 
they are in the editorial process, and do not come out for maybe five or 
six months. It could be that the person was not aware of it at the time they 
wrote it, and we would hope to try to catch it in the editorial process. After 
about a year and a half, if I remember the data, you see the citations drop 
off, because it becomes well known that the paper is retracted.175
Our predecessor’s report into Regenerative Medicine
95. The case of Paulo Macchiarini and UCL’s special investigation into research integrity 
(see Box 2) has some implications for our predecessor’s 2017 report on regenerative 
medicine. The Committee’s report noted that:
172 BMJ (RIN0081) para 1.a.iii
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In 2008, MRC-funded researchers at University College London carried out 
the first transplant of a human trachea (wind pipe) reconstructed using stem 
cells. By 2013, the group were ready to build on this success by developing 
the first clinical trials of a stem cell-derived larynx transplant in a project 
known as “RegenVOX”. The RegenVOX procedure involves preparing a 
reconstructed larynx made from the patient’s own stem cells and a donor 
larynx. The team removes the cells from the donor larynx, leaving behind a 
scaffold onto which the patient’s stem cells are grafted. This means that the 
new larynx will not be rejected by the immune system so patients do not 
need immunosuppressant medication.176
The Committee’s report also quoted a witness as referring to “the first successful transplant 
of a tissue-engineered trachea, utilising the patient’s own stem cells”.177
96. Since then, misconduct processes have revealed that the research on using stem cells 
to support artificial trachea transplants is not reliable, and is based on exaggerated patient 
outcomes (see Box 2). The ‘RegenVOX’ clinical trial of stem cell-based tissue-engineered 
laryngeal implants referred to above is now listed as ‘withdrawn’ on the Clinicaltrials.gov 
website.178 Having explored the issue of correcting the research record with our witnesses, 
we resolved to find a way of flagging the now contested evidence that the Committee 
received to readers of its report. We have arranged for a note to be attached at the relevant 
places in the online report with a forward reference to this inquiry. Our intention is to 
help readers of that earlier report to find further relevant information, not to alter the 
formal record of our predecessor’s work.
Recording sanctions on researchers
97. Dr Elizabeth Wager noted that there was an interest in a university keeping the 
outcome of any misconduct investigations quiet, which could lead to fraud occurring at 
other institutions in the future:
If results of investigations are kept confidential, or worse, if deals are made 
so that researchers are “let go quietly” with favourable or neutral references 
to avoid perceived bad publicity surrounding a proper investigation, 
researchers are likely to move to other institutions which are unaware of 
their track record, and the chance to rehabilitate or retrain them will be 
missed.179
There are examples of this happening in the UK; the case of neuroscientist Jatinder 
Ahluwalia was highlighted by Dr Wager as an example of a lack of communication between 
institutions and checking of references. According to a summary published by the Times 
Higher Education (THE), Ahluwalia was dismissed from the University of Cambridge’s 
doctoral programme in 1998 for suspected research misconduct, and subsequently 
completed a PhD at Imperial College London in 2002.180 He then took a postdoctoral 
position at University College London (UCL), working with Professor Anthony Segal. 
176 Science and Technology Committee, Fifteenth Report of Session 2016–17, Regenerative Medicine, HC 275, p26
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THE reported that in 2004, Professor Segal attempted to repeat Ahluwalia’s experiments 
after a paper from another group contradicted their findings. Ahluwalia left UCL in 2007, 
but in 2008 UCL started a misconduct investigation which concluded in 2010 that “it 
was beyond reasonable doubt that Ahluwalia had misrepresented his experiments […] 
deliberately” and “that it was likely that he had […] deliberately contaminated chemicals 
used in colleagues’ experiments “so as to falsify the results of those experiments in 
order to conceal the falsification by him of the results of his own experiments”.181 By 
then, Ahluwalia had moved to the University of East London. Following this revelation, 
Ahluwalia was dismissed from UEL in 2011.182 Dr Wager summed up this example as 
“four very reputable British universities not sharing information”.183
98. Professor C.K. Gunsalus noted that researchers found guilty of misconduct may 
also move from country to country. She knew of “five cases where individuals who were 
found to have committed research misconduct in the United States moved to the United 
Kingdom and are active researchers there, and vice versa—people who got into trouble in 
the UK and moved to the US and started anew. Recidivism is a fairly serious problem”.184
99. Dr Wager suggested that there was a need for ‘blacklisting’ of researchers or a licence 
to practice, to combat ‘serial fraudsters’:
I think the idea of some kind of licence or public list is a good one. They do 
it in Pakistan; if you get caught for plagiarism, there is a public website185 I 
can look at to find out if I want to employ you or not. I think that is a real 
area of concern.186
However, Dr Tony Peatfield, representing RCUK, was sceptical about maintaining a 
blacklist of researchers, on legal grounds:
You [would] have to have a process for striking off people. Somebody would 
have to complain, and then you go through a legal process to strike them 
off, because you are depriving somebody of the right to work. My personal 
view is that it would be extremely bureaucratic and expensive to set up and 
probably will not work very well. […] I am not a lawyer, but I understand 
that it may be illegal to blacklist people if it stops them working, so blacklists 
per se are not an option.187
Sir Mark Walport, the Chief Executive of UKRI, was similarly cautious about the legalities 
of maintaining a blacklist in relation to data handling, but commented that “subject to it 
being legal, I can see a good argument for doing it”.188
100. Dr Alyson Fox from the Wellcome Trust indicated that funders may in practice have 
their own blacklists:
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Typically, if someone has been found guilty of research misconduct, we, as 
a funder, would no longer receive any applications from them for funding 
for life, because we think it is serious. That is what we do.189
Dr Peatfield suggested that it was for the new employer to be diligent in its hiring process:
It crops up occasionally where somebody just moves from one institution to 
another. A report by Science Europe last year recommended that universities 
employing researchers should ask the question at interview, “Have any cases 
of misconduct been held against you?” If that person lies, that would be a 
reason for subsequent dismissal if they were then appointed. There is an 
onus on the new employer, or any employing institution, to ask those who 
are applying for jobs what their history has been.190
101. Cases of researchers committing misconduct at a string of institutions suggest 
that either some universities are using non-disclosure agreements to keep misconduct 
quiet, or are not being sufficiently diligent in checking references when hiring 
researchers. Hiding misconduct through non-disclosure agreements is not acceptable, 
not least as it effectively makes the institution complicit in future misconduct by that 
individual. The Government should ask UKRI to consider how this practice can be 
effectively banned by institutions receiving public funds, and statements to this effect 
should be included in a strengthened Concordat (see Chapter 3). Meanwhile, there is a 
need for greater diligence in employers checking for past misconduct, and for previous 
employers fully disclosing such information.
Communication to coordinate the response to problems with 
research integrity
102. Dr Wager suggested that there were currently problems with the various parts of the 
system not communicating properly with each other when investigating or responding 
to research integrity problems. She described “systematic failings to alert readers to 
potentially or actually unreliable research reports. This may be due to journals being 
reluctant to issue Expressions of Concern or to retract articles, or institutions being 
reluctant to investigate cases, or failing to investigate them properly, or failing to inform 
journals about investigations or their findings”.191
103. Dr Fox said that the Wellcome Trust’s grant conditions required institutions that it 
funds to report any investigations to them at the screening stage.192 Wendy Appleby, the 
Registrar at UCL, also commented on the information flow between research institutions 
and funders:
A topic of discussion between funders and universities is about when you 
disclose to a funder an allegation of research misconduct. We need to be very 
clear about the stage for that and about what a funder is going to do with 
it. Understandably, if an allegation is to be dealt with at one of the earlier 
stages, and is not going to go through to proven misconduct, researchers 
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are naturally concerned about their funders being informed of that. They 
have certain rights in terms of confidentiality as well. Clearer protocols and 
mechanisms for dealing with these things generally would be very useful.193
104. We were also alerted to the complexities of handling investigations that may span 
multiple research institutions, such as when a researcher moves to another university 
or when a project is undertaken at several locations. As with the interactions between 
funders, employers and publishers, such investigations also raise questions about when 
and how information is shared, how confidentiality is handled during the process, and 
how the risk of duplication of effort is managed. The Russell Group Research Integrity 
Forum has recently produced a ‘Statement of cooperation in respect of cross-institutional 
research misconduct allegations’, emphasising the need to provide clarity on when a 
researcher’s right to confidentiality “might be overridden by an institution’s duty to uphold 
the integrity of research carried out in its name”.194 The statement commits Russell Group 
members to contacting associated parties at the outset and agreeing with them how to 
proceed.
105. Although the Concordat to Support Research Integrity includes a commitment to 
deal with allegations of misconduct using “transparent, robust and fair” processes, it does 
not discuss the liaison required between different parties that may be involved, beyond 
stating that employers of researchers should provide information to funders “as required 
by their conditions of grant and other legal, professional and statutory obligations”.195
106. Researcher mobility means that research misconduct investigations may 
require coordination between current and former employers, and between journals 
and funders. We are encouraged to see the Russell Group developing protocols 
for communicating with related parties when dealing with allegations that cross 
institutional boundaries. There is a need for all parts of the system to work together—
including employers, funders and publishers of research outputs—but there appear to 
be problems with the required sharing of confidential information. We recommend 
that employers, funders and publishers of research work together to agree a protocol for 
information-sharing on researchers involved in research integrity problems in a way 
that meets employment protection legislation. Commitments in this vein could form 
part of a tightened Concordat (see Chapter 3).
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6 Regulating research and researchers
107. The UK has an enviable reputation for high-quality research. In 2013, the UK 
accounted for almost 16% of the world’s most highly cited research articles, despite 
having less than 1% of the global population and around 4% of researchers.196 Meanwhile, 
researchers themselves are one of the most highly-trusted groups in the eyes of the UK 
public. The 2017 IPSOS Mori Veracity Index suggests that 85% of British adults trust 
“professors” to tell the truth, higher than judges and the police, and considerably higher 
than politicians at 17%.197
108. However, as Professor Stephan Lewandowsky and Professor Dorothy Bishop put it, 
“science […] has to be conducted according to rigorous standards to be effective. Where the 
integrity of research is compromised by dishonesty, conflict of interest or incompetence, 
there can be major impacts on public health and safety”. Similarly, Universities UK 
noted the importance of public confidence in research, and observed that “wherever this 
confidence is undermined, either through poor practice or misconduct, then public trust 
in—and support for—research can be shaken”.198
109. High-profile cases of research misconduct in other countries have prompted changes 
in the way in which research integrity is managed. For instance, in the USA, the Office of 
Research Integrity was created following research misconduct cases at four major research 
centres in 1980.199 In general, we were told that many countries follow a similar path: 
“a problem occurs; there is a question about whether oversight and regulation would be 
useful; there is significant pushback, with people saying regulations are terrible and they 
will do bad things and interfere with scientific progress. The regulation occurs; people 
normalise it and things stabilise a bit. Then another problem occurs so they look at it 
again”.200
110. UK research has an enviable record of excellence and public trust, but this should 
not be taken for granted. There is a risk that public trust in science could be eroded in 
the future through high-profile examples of research misconduct, and a risk that this 
could lead to demands for knee-jerk and ill-advised changes to the research system in 
the UK. There is a need for the research community—including funders, publishers, 
and employers of researchers—to stay ahead of research integrity issues and how they 
are dealt with in public policy. The UK’s position of international high regard and 
public trust in researchers is strengthened if the community has the confidence to 
admit that no area of human endeavour is immune to misconduct and error at some 
scale.
111. UKRIO’s position statement explains that the UK system is based on the responsibility 
to investigate misconduct usually resting with the employer:
When issues of research [mis]conduct arise, if a field of research is not 
governed by statute, it normally devolves to the relevant employer—such 
as a university, NHS body or private sector organisation—to investigate 
196 Elsevier, International Comparative Performance of the UK Research Base (December 2013), p2
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and, if necessary, take remedial action. […] In turn, research funding 
bodies, via contractual mechanisms, help ensure that employers fulfil their 
responsibilities.201
Sir Mark Walport (speaking then as the Director of the Wellcome Trust) told our 
predecessors in 2011 that research integrity was “an intrinsic responsibility of an employer. 
It is not something they should be delegating to somebody else”. Similarly, Universities 
UK argued that:
Universities—as autonomous institutions—are responsible for responding 
to and investigating allegations of research misconduct, and ultimately 
have the final decision on whether an allegation of research misconduct is 
upheld. Universities may also apply sanctions up to and including dismissal, 
subject to employment law. This is a responsibility that universities take very 
seriously, and have a significant interest in ensuring policies and processes 
are fit for purpose and in line with best practice.202
112. However, we also heard that current arrangements of institutions “policing their own 
conduct” could represent a conflict of interests.203 Retraction Watch observed that “given 
many cases we have covered in which universities cleared their scientists of misconduct, 
only to later be forced to acknowledge such misconduct, it is obvious that institutions have 
a conflict of interest in investigating their own employees”.204 Professor Dorothy Bishop 
called for an ombudsman to be created in the UK in order to manage this conflict of 
interest, and argued that this would be a benefit to the community in being able to defend 
itself against accusations of impropriety:
It would be sensible to have an independent arbiter, who has to be independent 
from Government and from the universities. They would be more like an 
ombudsman, but would need expertise in statistics and methods so that 
they could examine data, and they should have teeth so that they could take 
steps. Obviously, that would not be non-trivial to set up, but it would benefit 
the scientists who sometimes come under attack from people with vested 
interests, the people who are concerned about fraud, and the institutions 
themselves, who otherwise have to deal with those very messy cases.205
113. In contrast, Professor Sir Ian Diamond (on behalf of UUK) argued that it was already 
in a university’s interest to investigate misconduct properly:
It is easy to say that there is a conflict of interest, but […] universities have an 
enormous interest in their own reputation and maintaining it. Universities 
have a long history of being able to co-regulate in an effective way. […] It is 
in everybody’s interest to get to the bottom of the problem.206
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Self-regulation in the UK
114. UKRIO’s November 2016 position statement on statutory regulation of research 
integrity notes that “ultimately, all countries and jurisdictions rely on self-regulation by 
researchers”, but that “what varies are the structures set up to support and oversee this 
self-regulation and to ensure that action is taken when needed”.207 It explains that:
There is currently no overall statutory regulation of research or of researchers 
in the UK. While there are regulators for certain types of research, such as 
human clinical trials or research involving animal subjects, and for certain 
types of researchers, such as (medical) doctors, these are exceptions rather 
than the rule.208
115. Our predecessor committee concluded in 2011 that the general oversight of research 
integrity in the UK was “unsatisfactory”, and recommended that an external regulator 
for research integrity should be established.209 The Government declined to act on this 
recommendation, stating:
the Government does not agree that there is a case for setting up an external 
regulator to oversee the employers [of researchers]. There are already a 
number of regulatory and licensing bodies in key areas of research, and 
therefore any new regulatory body would increase regulatory burden on 
employers, and risks causing unnecessary overlap and uncertainty. Through 
the Research Integrity Concordat the Government will expect employers 
of researchers to deal with research integrity in an open and transparent 
manner.210
116. The written evidence we received suggests that there is still strong resistance within 
the university sector to the idea of a regulator. The Russell Group argued that “the creation 
of a UK regulatory body to oversee compliance would run the risk of undoing the progress 
made in strengthening the rigor and culture of UK research, by discouraging transparency 
and undermining the credibility of positive messages”.211 The Group also suggested that 
“a culture which places an emphasis on compliance with rules can be counterproductive, 
as it may encourage people to do the minimum, just enough to comply, as opposed to 
incentivising people to strive to improve research behaviours and practices”.212 Similarly, 
Universities UK argued that “policing researchers via a compliance-led policy focus risks 
distancing researchers from the importance of pursuing best practice, and instilling 
undesirable attitudes towards the promotion of research integrity […] It is unclear how 
further regulation can address poor research culture or promote good practice”.213
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117. The Government’s position is that the “primary responsibility” for research integrity 
lies with the researchers themselves, with an “overarching responsibility” at the institutional 
level. The Government argued that formal regulation would be “overly bureaucratic, 
difficult to implement” and would risk “hampering the research endeavour”.214
International examples
118. We were directed to a range of international examples of research integrity systems, 
including those in Australia (see Box 3), Canada (Box 4), Denmark (Box 5) and the 
USA. Our attention was drawn specifically to systems that provide a means of assuring 
that employers have conducted misconduct investigations in an appropriate way, while 
retaining the onus on the employer to conduct the investigation. Dr Elizabeth Wager 
explained that:
One model that has a lot of merit is the Australian system, where the 
first response lies with the university. That is the prime responsibility to 
investigate, and it is an important principle. We do not have some big 
expensive body trying to do the investigations. However, in the last four 
or five years, they have set up an independent but national committee on 
research integrity that acts like a court of appeal. If the university has not 
done a good job, if people are unhappy or it is too slow, or to collate best 
practice and give advice, they have that extra layer. That is something we 
really lack in the UK.
[…] We do not have anything that universities, individuals or whistleblowers 
can turn to if a university does not do a good job. Often they investigate well, 
but there are cases when they do not investigate well, and that is when the 
system really falls down, because we just say, “Well, they are autonomous 
and secretive,” and there the matter ends.215
119. We asked the Australian Research Council to provide some further information 
on the work of the Australian Research Integrity Committee (ARIC—see Box 3). We 
also sought reflections from Australian academics, who told us that there was still 
a lack of transparency within the Australian system in terms of the total numbers of 
investigations—ARIC reviews only a very small number of contentious cases each year 
and most information on misconduct processes is not public. Neither does ARIC play 
a role in promoting responsible research or providing advice on training, which, we 
were told, means that its impact will only be on one part of the system (poorly handled 
misconduct cases). We were pointed towards Canada as an example of a system which 
includes this wider role alongside reviewing whether investigations have been conducted 
appropriately (see Box 4).
120. Professor C. K. Gunsalus, an American academic, provided some information on the 
equivalent part of the research integrity system in the USA, which goes slightly further 
than in other countries:
The institution is obliged to report when it initiates an inquiry and to 
submit its investigation report. The two federal agencies, the Office of 
214 Department of Business, Energy & Industrial Strategy (RIN0016)
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Research Integrity for the Department of Health and Human Services and 
the Office of Inspector General for the National Science Foundation, review 
those reports and have the ability to query them and send them back to the 
institution and say, “You’ve missed the mark. Do it over again,” which they 
do with some regularity, before they accept the institutional findings.216
121. We asked Dr Ivan Oransky, from Retraction Watch, whether there were research 
integrity systems in other countries that the UK could seek to emulate. He highlighted 
transparency as a key issue:
For me, the best system would be to pick the best from each and avoid 
the worst in each. […] In Japan, there is a legal obligation that, when there 
is a finding of misconduct, the university must issue at least an executive 
summary. They often issue a fairly substantial investigation report. We 
think that is good for transparency. Personally, I would like to see them 
release details when there is not such a finding. Of course, I understand that 
one is innocent until proven guilty, and all those considerations.217
Box 3: Research Integrity in Australia
The Australian Research Integrity Committee (ARIC) was jointly established by the 
Australian Research Council and the National Health and Medical Research Council 
in 2011. It is jointly administered by these two bodies, with the secretariat provided 
by the relevant funding agency in each case.
ARIC does not replace institutional investigation of research misconduct. Research 
institutions maintain their autonomy and are responsible for investigating allegations 
of research misconduct in the first instance.
ARIC provides a review system of institutional processes to respond to allegations of 
research misconduct. This system is intended to ensure that institutions investigate 
such allegations and observe proper process in doing so.
Specifically, the ARC and the NHMRC jointly administer the ARIC to:
• Review the process by which a nominated institution has managed an 
allegation of research misconduct;
• Provide findings and, where relevant, recommendations to the CEO of the 
ARC and/or the CEO of the NHMRC; and
• Publish de-identified information on its activities at least annually.
The ARIC considers whether the institution’s response to the allegation of research 
misconduct was consistent with the framework outlined in the Code and with 
the institution’s policies and procedures for investigating allegations of research 
misconduct.
Source: “Australian Research Integrity Committee”, Australian Government (accessed 20 June 2018)
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Box 4: Research Integrity in Canada
In Canada, the Panel on Responsible Conduct of Research (PRCR, established in 
2011) reviews institutional investigations, but also has a wider function of promoting 
research integrity.
A framework agreed by the three federal research agencies sets out policies and 
requirements related to applying for and managing Agency funds, performing 
research, disseminating results, and the processes that institutions and agencies 
follow in the event of an allegation of a breach of the policy.
The PRCR:
• reviews institutional investigation reports;
• recommends recourse in cases of confirmed breaches, if appropriate, consistent 
with the Framework;
• provides advice to the Agencies on matters related to the responsible conduct 
of research; and
• provides advice to the Agencies on future revisions to the Framework.
The PRCR helps to foster a research environment that supports and promotes the 
responsible conduct of research by undertaking “educational outreach to the research 
community”. It has a role to “enhance public trust in research activities undertaken 
under the auspices of Canadian institutions and organizations receiving funding 
from the Agencies.”
The PRCR also publishes anonymised summary information on every confirmed 
breach of the Framework, in three-year instalments. Each summary contains 
a distillation of the facts as established through the institutional inquiry or 
investigation, as well as a description of the recourse exercised by the institution and 
the relevant Agency. Such recourse is not within the authority of or required by the 
Agencies, but was implemented by the institutions within their absolute discretion to 
impose employment-related recourse measures such as suspensions or termination 
of employment. The summaries are anonymized, in keeping with provincial and 
federal privacy legislation.
Source: Government of Canada, ‘Panel on Responsible Conduct of Research’, accessed 20 June 2018
Box 5: Research Integrity in Denmark
The Danish Committee on Research Misconduct was established in 1992, initially 
on a trial basis and made permanent in 1999. In 2017 a system of sub-committees 
was replaced by a single research misconduct committee with a High Court judge 
as chairman and 8–10 recognized researchers as members representing different 
scientific areas. The DCRM is an independent body under the Danish Ministry of 
Higher Education and Science where the DCRM secretariat is situated.
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A recent Act of Parliament in Denmark separates research integrity into three parts:
Responsible conduct of research is developed in the research community based on 
common guidelines and practices laid down in non-legal settings such as the Danish 
Code of Conduct for Research Integrity;
Questionable Research Practices are handled by the individual institutions who are 
legally obliged to deal with such issues and publish guidelines for their processes in 
this regard;
All research misconduct cases—defined in the law as fabrication, falsification and 
plagiarism—will be handled by the DCRM.
All allegations of suspected breaches of research integrity matters must be brought to 
the relevant institution for an initial assessment. If it is a case of research misconduct 
and the following conditions are met, the institution must forward the case to the 
DCRM with a report on the facts of the case:
The allegation must relate to a scientific product, for example a scientific paper, a 
Ph.D. thesis or similar.
The allegation must relate to a researcher having contributed to the scientific product 
in question.
The allegations put forward must concern research misconduct. Questions about 
scientific disagreements, the quality of research and questionable research practice is 
outside the mandate of the DCRM.
The allegations put forward are reasoned by the complainant.
Meanwhile, the Danish Code of Conduct for Research Integrity provides the 
research community with a framework to promote commonly agreed principles 
and standards. The Code of Conduct aims to support a common understanding and 
common culture of research integrity in Denmark.
The DCRM is required to publish an annual report on questionable research practice 
in Denmark based on annual reporting from the institutions to the Committee. In 
this respect the Committee works toward strengthening the credibility of Danish 
research, prevent research misconduct and support the effort on research integrity as 
expressed in the Danish Code of Conduct for Research Integrity
Sources: ENRIO, ‘Denmark’, accessed 20 June 2018; Mathias Willumsen (RES0043)
122. We see a gap in the UK system for a body that can provide a means of 
independently verifying whether a research institution has followed appropriate 
processes to investigate misconduct, as in Australia and Canada. We recommend 
that the Government ask UKRI to establish a new national committee which could 
undertake this role. Employers should still have the first responsibility for investigating 
and taking action in response to allegations of research misconduct, but there should be 
a means of checking that processes have been followed appropriately. The new committee 
should be able to recommend to UKRI that funding be restricted or reclaimed if an 
employer has not followed appropriate processes in responding to research misconduct. 
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While established under the auspices of UKRI, the new committee should have its own 
secretariat and sufficient independence from it so that it can act in cases where the 
research is not funded by UKRI. Without a body along the lines we suggest there is a risk 
that demands for statutory regulation will grow in the future. We recognise that there 
is a strong consensus within the community about the disadvantages that overbearing 
regulation could bring. We argue, however, that the onus is now on the community to 
support steps to avoid this.
123. We recommend that the national committee should also have formal responsibility 
for promoting research integrity, as the equivalent body does in Canada. Working 
with Universities UK, the new committee should take responsibility for driving the 
implementation of an updated and strengthened Concordat, and following up on other 
recommendations to the sector in this report. Meanwhile, UKRIO should continue its 
work in providing advice on research integrity and sharing best practice. It should now 
advise UKRI on the creation of the new body, including its work methods, drawing on 
the best international examples.
Monitoring trends
124. We noted in Chapter 1 that the available data on research integrity problems is 
limited. As Dr Elizabeth Wager argued, “without clear [annual narrative] statements 
about misconduct investigations it is impossible to estimate the extent of problems in 
the UK or to ensure that institutions are handling them appropriately”.218 She noted that 
an annual report on the overall state of research integrity across the UK has never been 
produced,219 and UUK agreed that “more consistent and comprehensive reporting of data 
on the number and scope of investigations may be valuable”.220
125. To our surprise, the Royal Society disagreed, telling us that “it is not helpful to seek 
to quantify the ‘research integrity problem’”, since “in an environment where the answer 
is not always clear cut, a lot of time can be spent discussing how to quantify the problem 
rather than looking for ways to solve it”.221 Professor Leyser expanded on this point by 
arguing that “getting meaningful and robust information about the size of the research 
integrity problem is very difficult and potentially very expensive […] It seems much more 
productive to work to change the culture so that those problems are less prevalent”.222
126. An RCUK requirement since April 2017 is that the institutions that it funds should 
report instances of potential misconduct to the research council at the screening phase—
considerably earlier than previous requirements.223 This should in principle provide 
further data on the overall rates of misconduct, at least in the bodies that RCUK funds. 
UKRIO told us that it will shortly begin a programme of research into research integrity 
in the UK, including assessing “the extent and scope of challenges to and breaches of 
research integrity in the UK”.224 This aligns closely with the themes in our report, and we 
hope that the sector will pay close attention to UKRIO’s findings.
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Research Councils UK, January 2018
224 UK Research Integrity Office (RES0023)
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127. Several international systems for monitoring and responding to problems with 
research integrity include regular reporting or collection of information at the national 
level (see Boxes 3 to 5). We also note that annual statements from universities are also 
an opportunity for an institution to report on the proactive steps that it has taken to 
improve research integrity, including training undertaken and policies reviewed. As well 
as a means of providing transparency, it is an opportunity for employers of researchers to 
demonstrate that they are taking research integrity seriously.
128. Transparency is a key feature of a healthy research integrity system. The new 
national research integrity committee we recommend should publish an annual report 
on the state of research integrity in the UK, looking across the whole of research, 
and collecting information on: retractions; misconduct investigations and their 
outcomes; Concordat compliance; and training undertaken. The data for this will 
come from university narrative statements and the aggregated data on screening-phase 
investigations that UKRI is now being provided with. The proposed national committee 
should also consider how best to engage industry with the issue of research integrity, 
and should incorporate meaningful information on this aspect in its annual report.
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Conclusions and recommendations
Introduction
1. The Science Minister’s initial reluctance to give evidence to our inquiry was 
disappointing, not least as it risked sending the message that the Government 
does not take this issue seriously. Nevertheless, we welcome the fact that that the 
Minister was subsequently willing to appear and are grateful for his responses to 
our questions. (Paragraph 8)
2. The Government rightly invests considerable sums of public money in research, 
and investment in research and development as a proportion of GDP is set to grow 
further in the coming years. The Government needs to be confident that all possible 
steps are being taken to ensure that this money is not wasted through problems 
with research integrity, and that the research that it buys is as reliable as possible. 
While the Government should not seek to interfere directly in research matters 
or compromise the independence of universities, it should nevertheless maintain 
an active interest in supporting research integrity and ensuring that all elements 
of self-regulation are functioning well in order to get the best value possible from 
public investment. (Paragraph 9)
Understanding and measuring ‘research integrity’
3. The available data on misconduct investigations suggest that serious research 
misconduct is rare, but it is impossible to be certain without better data. There 
is a mismatch between the number of investigations and the scale of reported 
temptations to compromise on research standards, the ‘reproducibility crisis’ in 
some disciplines, the growth in journal article retraction rates, and trends in image 
manipulation. We hope that most researchers will never succumb to the temptations 
to compromise on research standards, and some of these trends may be the product 
of increased detection and correction of honest errors. Nevertheless, it is worrying 
that there seem to be so few formal research misconduct investigations conducted 
by universities. Increases in the number of investigations should be seen as a healthy 
sign of more active self-regulation. Further work is needed to determine the scale of 
the problem. (Paragraph 28)
The Concordat to Support Research Integrity
4. Most universities take their research integrity responsibilities seriously, but progress 
in implementing the Concordat to Support Research Integrity across the whole 
sector is disappointing. Six years on from the signing of the Concordat, the sector 
as a whole still falls some way short of full compliance in terms of publishing an 
annual statement, which risks giving the impression of pockets of complacency. 
We were surprised by the reasons that some universities gave for not publishing 
an annual statement on research integrity as recommended by the Concordat. 
The majority of universities have successfully balanced transparency against 
confidentiality in producing an annual statement, but a few are lagging behind and 
see transparency as a threat to their public image. Publishing an annual statement 
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is a positive opportunity for an institution to set out the steps that it is taking to 
safeguard research standards, as well as to report on the number of investigations. 
We were encouraged that our letter to all Universities UK members prompted 
some of them to take steps to improve their compliance with the Concordat. More 
leadership is required to drive the implementation of the Concordat across the 
whole of the research sector, and we return to this issue in Chapter 6. We welcome 
Universities UK’s plans to convene a Research Integrity Forum meeting to consider 
our recommendations relating to the Concordat and look forward to seeing the 
results of their work. (Paragraph 39)
5. Compliance with the Concordat has technically been a condition of receiving 
funding from research councils and higher education funding councils since 2013, 
but meaningful sanctions have never been deployed. The Concordat contains 
mainly high-level statements rather than explicit measurable requirements, and 
comprehensive information on ‘compliance’ is not collected by the funders. We 
recommend that the signatories update and strengthen the Concordat by making the 
requirements and expectations clearer, and produce a route map and timetable for 
reaching 100% compliance with the strengthened version within the next year. UKRI 
should collect and publish details of universities that are not compliant. In particular, 
the Concordat should be strengthened in relation to training on research integrity 
(discussed in Chapter 4), processes for responding to allegations of misconduct (see 
Chapter 5), commitments to clinical trials transparency (which we will return to in a 
dedicated report) and publication of ‘negative’ research results. (Paragraph 43)
6. We endorse the Government Chief Scientific Adviser’s call for Government 
departments to sign up to the Concordat on Research Integrity to ensure consistency 
of approaches to research governance. If the Concordat is suitably strengthened, 
as we recommend above, this will be a useful step forward. We look forward to 
receiving further details of actions taken by the departments in response to his 
initiative in the Government’s response to this report. (Paragraph 46)
Supporting and promoting the integrity of research
7. It is surprising that most UK universities are not subscribers to the UK Research 
Integrity Office. The result is that the profile and impact of UKRIO might be highest 
with the institutions which already choose to participate, rather than the ones that 
might need the most help. The default assumption for all universities should be that 
they are subscribers to UKRIO, unless they can explain why they do not need to use 
UKRIO’s advisory services. We recommend that the Government and Universities 
UK write jointly to all universities to encourage them to engage with UKRIO and 
consider subscribing to its services. (Paragraph 50)
8. Creating a healthy ‘research culture’ is just as important as tackling lapses in 
research integrity, and would help ensure that a career in research is attractive to 
those who value rigour, accuracy, honest and transparency. We endorse Research 
England’s plans to require the REF 2021 assessors to consider how research integrity 
issues can be taken into account. We hope that this will underline the importance 
of research integrity to a healthy research environment, and counterbalance some 
of the pressures to compromise on integrity. For this to be successful it must be 
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implemented in a way that encourages universities to be more transparent about 
research integrity and investigations, rather than an additional incentive to avoid 
drawing attention to lapses in integrity. (Paragraph 57)
9. There is a need to understand more fully the effects of the current funding system 
on researcher and institutional behaviour, and consider how unwanted effects 
can be minimised. We recommend that UKRI commission research to understand 
the effects of incentives in the research system on researcher behaviour and assess 
where adjustments or counterbalances may be needed to support research integrity. 
(Paragraph 58)
10. We are encouraged to hear that some universities make training in research integrity 
a mandatory part of doctoral studies and include it in their research supervisor 
training programme. It is important that the attitudes to research integrity 
transmitted to the next generation of researchers are the right ones, and that those 
supervising them are also suitably trained. We recommend that UKRIO provide 
guidance to universities on best practice in delivering training to doctoral supervisors. 
(Paragraph 66)
11. The research councils do not have reliable information on what training is currently 
being delivered. The increased concentration of training, through ‘Centres for 
Doctoral Training’, presents an opportunity for monitoring whether suitable 
training on research integrity is being provided as part of a PhD. We recommend 
that UKRI assess whether suitable training is being provided in line with current 
requirements and report back to us on its findings. UKRI should also consider further 
the case for centralised provision of training on research integrity, or standards that 
could be set. (Paragraph 67)
12. We recommend that UKRI consider how best to encourage research teams to engage 
with statisticians as part of their research, and how best to improve the statistical 
competencies of researchers in general. (Paragraph 68)
13. We are encouraged to see moves towards open publishing of datasets, and steps 
being taken to improve reporting of research methods through reporting checklists. 
However, we also recognise the need for protocols for accessing research data to 
ensure that secondary analysis is conducted appropriately. The Centre for Data 
Ethics and Innovation should consider further how best to balance the need for data 
to be openly shared with the need to ensure that data is used responsibly in secondary 
analysis. (Paragraph 75)
Detecting and responding to problems with research integrity
14. There is a continuing need for publishers to invest in techniques and technologies 
to spot problems with research papers. While the purpose of peer review is not to 
detect fraud, the sector’s responsibility for the integrity of the research base includes 
taking reasonable steps to ensure that technology to detect problems is developed 
and put to good use. This may be an area in which market forces do not obviously 
support this investment of resource. A Concordat-style set of commitments in the 
academic publishing community to invest jointly in software for the detection of 
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image manipulation—or common standards for checking images—may be required. 
We recommend that UKRIO convene a discussion with publishers to explore this. 
(Paragraph 82)
15. Universities and other employers of researchers need to be able to demonstrate 
that they are following best practice in the way that investigations are conducted. 
The annual narrative report recommended by the Concordat (see Chapter 3) 
is one opportunity for institutions to review their processes and set out whether 
they reflect UKRIO’s guidance. Any suggestion that best practices are not being 
followed is a concern, particularly given the reputational risk of, for example, not 
using external panel members in some stages of the process. UKRIO’s guidance on 
misconduct processes was published in 2008; it is worrying that, ten years on, some 
institutions may not yet have acted on it. We recommend that following best practice 
in use of external panel members form an explicit part of a strengthened Concordat. 
(Paragraph 88)
16. Cases of researchers committing misconduct at a string of institutions suggest that 
either some universities are using non-disclosure agreements to keep misconduct 
quiet, or are not being sufficiently diligent in checking references when hiring 
researchers. Hiding misconduct through non-disclosure agreements is not acceptable, 
not least as it effectively makes the institution complicit in future misconduct by 
that individual. The Government should ask UKRI to consider how this practice can 
be effectively banned by institutions receiving public funds, and statements to this 
effect should be included in a strengthened Concordat (see Chapter 3). Meanwhile, 
there is a need for greater diligence in employers checking for past misconduct, and for 
previous employers fully disclosing such information. (Paragraph 101)
17. Researcher mobility means that research misconduct investigations may require 
coordination between current and former employers, and between journals and 
funders. We are encouraged to see the Russell Group developing protocols for 
communicating with related parties when dealing with allegations that cross 
institutional boundaries. There is a need for all parts of the system to work 
together—including employers, funders and publishers of research outputs—but 
there appear to be problems with the required sharing of confidential information. 
We recommend that employers, funders and publishers of research work together to 
agree a protocol for information-sharing on researchers involved in research integrity 
problems in a way that meets employment protection legislation. Commitments in 
this vein could form part of a tightened Concordat (see Chapter 3). (Paragraph 106)
Regulating research and researchers
18. UK research has an enviable record of excellence and public trust, but this should 
not be taken for granted. There is a risk that public trust in science could be eroded 
in the future through high-profile examples of research misconduct, and a risk that 
this could lead to demands for knee-jerk and ill-advised changes to the research 
system in the UK. There is a need for the research community—including funders, 
publishers, and employers of researchers—to stay ahead of research integrity issues 
and how they are dealt with in public policy. The UK’s position of international 
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high regard and public trust in researchers is strengthened if the community has 
the confidence to admit that no area of human endeavour is immune to misconduct 
and error at some scale. (Paragraph 110)
19. We see a gap in the UK system for a body that can provide a means of independently 
verifying whether a research institution has followed appropriate processes to 
investigate misconduct, as in Australia and Canada. We recommend that the 
Government ask UKRI to establish a new national committee which could undertake 
this role. Employers should still have the first responsibility for investigating and taking 
action in response to allegations of research misconduct, but there should be a means of 
checking that processes have been followed appropriately. The new committee should 
be able to recommend to UKRI that funding be restricted or reclaimed if an employer 
has not followed appropriate processes in responding to research misconduct. While 
established under the auspices of UKRI, the new committee should have its own 
secretariat and sufficient independence from it so that it can act in cases where the 
research is not funded by UKRI. Without a body along the lines we suggest there is 
a risk that demands for statutory regulation will grow in the future. We recognise 
that there is a strong consensus within the community about the disadvantages that 
overbearing regulation could bring. We argue, however, that the onus is now on the 
community to support steps to avoid this. (Paragraph 122)
20. We recommend that the national committee should also have formal responsibility 
for promoting research integrity, as the equivalent body does in Canada. Working 
with Universities UK, the new committee should take responsibility for driving the 
implementation of an updated and strengthened Concordat, and following up on other 
recommendations to the sector in this report. Meanwhile, UKRIO should continue its 
work in providing advice on research integrity and sharing best practice. It should now 
advise UKRI on the creation of the new body, including its work methods, drawing on 
the best international examples. (Paragraph 123)
21. Transparency is a key feature of a healthy research integrity system. The new 
national research integrity committee we recommend should publish an annual 
report on the state of research integrity in the UK, looking across the whole of 
research, and collecting information on: retractions; misconduct investigations and 
their outcomes; Concordat compliance; and training undertaken. The data for this 
will come from university narrative statements and the aggregated data on screening-
phase investigations that UKRI is now being provided with. The proposed national 
committee should also consider how best to engage industry with the issue of research 
integrity, and should incorporate meaningful information on this aspect in its annual 
report. (Paragraph 128)
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Annex: Summary of Universities UK member responses on 
implementation of the Concordat to Support Research Integrity
The table below provides a summary of the responses we received to our letter to all Universities UK members in November 2017. The full responses, 
and further summary data, are available for reference online. Wherever possible, information provided in the responses has been supplemented 
with contact details obtained through searching the institution’s website.
Table 1: UUK member contact details for research integrity
Institution Research integrity responsibility Contact address Other research integrity contact
Aberystwyth 
University
Gary Reed, Director, Department of Research, 
Business and Innovation
gar@aber.ac.uk; ethics@aber.ac.uk Mitchell Parker, Research Ethics and 
Integrity Officer (mip32@aber.ac.uk)
Anglia Ruskin 
University
Dr Michael Millan, Director, Research and 
Innovation Development Office
michael.millan@anglia.ac.uk Julie Scott, Research Ethics and Integrity 
Manager (julie.scott@anglia.ac.uk)
Aston University Dr Nichola Seare, Chair of the University Ethics 
Committee
n.seare@aston.ac.uk
Bangor University Dr Garry Reid, Director of the Research and 
Enterprise Office
g.reid@bangor.ac.uk Professor Jo Rycroft-Malone, Pro-Vice 
Chancellor for Research, Innovation and 
Impact—formal investigations (j.rycroft-
malone@bangor.ac.uk)
Bath Spa University Professor John Strachan, Vice-Provost 
(Research & Enterprise)
j.strachan@bathspa.ac.uk researchsupportoffice@bathspa.ac.uk
Birkbeck, University 
of London
Professor Matthew Innes, Vice-Master m.innes@bbk.ac.uk Dr Sarah Lee, Head of Research Strategy 
Support (sarah.lee@bbk.ac.uk)
Birmingham City 
University
Professor Keith A Osman, Director of Research keith.osman@bcu.ac.uk
Bournemouth 
University
Professor John Fletcher, Pro Vice-Chancellor 
for Research and Innovation
researchintegrity@bournemouth.
ac.uk
Brunel University 
London
Professor Geoff Rodgers, Deputy Vice-
Chancellor (Research & Innovation)
Research-Integrity@brunel.ac.uk res-ethics@brunel.ac.uk
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Institution Research integrity responsibility Contact address Other research integrity contact
Buckinghamshire 
New University
Sean Mackney, Pro Vice-Chancellor Sean.Mackney@bucks.ac.uk
Canterbury Christ 
Church University
Head of Centre/School red.resgov@canterbury.ac.uk
Cardiff Metropolitan 
University (UWIC)
Professor Scott Fleming, Director of Research 
and Graduate Studies
sfleming@cardiffmet.ac.uk
Cardiff University Professor Hywel Thomas, Pro-Vice-Chancellor 
for Research, Innovation and Engagement
via Sarah Wallace wallaces1@
cardiff.ac.uk
Dr Kathy Pittard Davies, Deputy Director 
& Head of Research Governance and 
Contracts (davieskp2@cardiff.ac.uk)
City, University of 
London
Professor Andrew Jones, Vice-President 
(Research & Enterprise)
andrew.jones.3@city.ac.uk Anna Ramberg, Research Governance 
& Integrity Manager (anna.ramberg.1@
city.ac.uk)
Coventry University Professor Olivier Sparagano, Associate Pro-
Vice-Chancellor (Research) and Chair of Ethics 
Strategy Group
olivier.sparagano@coventry.ac.uk
Cranfield University Professor Tom Stephenson, Pro-Vice-
Chancellor for Research and Innovation
T.Stephenson@cranfield.ac.uk
De Montfort 
University
Professor Andrew Collop, Deputy Vice-
Chancellor
acollop@dmu.ac.uk Laurence Gardiner, Head of Research 
Support (research@dmu.ac.uk)
Durham University Professor Claire Warwick, Pro-Vice-Chancellor 
for Research
pvc.research@durham.ac.uk
Edge Hill University Dr Nikki Craske, Director of the Research 
Office
Not specified research@edgehill.ac.uk
Edinburgh Napier 
University
Elaine Lambie, Clerk of University Research 
Integrity Committee
e.lambie@napier.ac.uk Elaine Lambie, Clerk of University 
Research Integrity Committee 
(e.lambie@napier.ac.uk)
Falmouth University Alan Murray, Deputy Vice Chancellor 
(Academic)
research@falmouth.ac.uk
Glasgow Caledonian 
University
The PVC and VP (Research) Not provided
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Institution Research integrity responsibility Contact address Other research integrity contact
Glyndwr University Professor Richard Day, PVC for Research Not provided
Goldsmiths, 
University of London
Professor Simon McVeigh, Academic Director 
for Research Policy, and Chair of the Research 
Ethics and Integrity Sub-Committee
via Karen Rumsey, Committee 
Secretary k.rumsey@gold.ac.uk
Guildhall School of 
Music and Drama
Head of Research Not provided
Heriot-Watt 
University
Not provided Not provided
Heythrop College Ethics Officer Not provided
Imperial College 
London
Professor Nick Jennings, Vice-Provost 
(Research and Enterprise)
n.jennings@imperial.ac.uk
Keele University Professor David Amigoni, Pro Vice-Chancellor 
for Research and Enterprise
d.amigoni@keele.ac.uk Dr Clark Crawford, Head of Research 
Integrity (research.governance@keele.
ac.uk)
King’s College 
London
Marice Lunny, Head of Research Policy and 
Ethics
marice.lunny@kcl.ac.uk
Kingston University Pro Vice Chancellor (Research, Business & 
Innovation)
Lancaster University Becky Gordon, Research Support and Systems 
Manager
b.gordon@lancaster.ac.uk Head of Research Services
Leeds Beckett 
University
Jenny Share, Secretary and Registrar
Leeds Trinity 
University
Professor Ray Lloyd, Deputy Vice-Chancellor Dr Helen Morris, University Research 
Officer
Liverpool Hope 
University
Revd Canon Professor Kenneth Newport, Pro 
Vice-Chancellor (Academic)
knewport@hope.ac.uk
Liverpool John 
Moores University
Alan Welby, Director of Research & Innovation 
Services
A.R.Welby@ljmu.ac.uk
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Institution Research integrity responsibility Contact address Other research integrity contact
London Business 
School
Professor Madan Pillutla, Deputy Dean 
(Faculty) and Dr Rosemary Vipond, Director, 
Research and Faculty Office
mpillutla@london.edu
London 
Metropolitan 
University
Research ethics review panels in each school
London School of 
Hygiene and Tropical 
Medicine
Lucinda Parr, Secretary lucinda.parr@lshtm.ac.uk Head of Research Governance and 
Integrity Office
London South Bank 
University
Professor Peter Doyle, Research Environment 
Manager
doylep8@lsbu.ac.uk
Loughborough 
University
Jackie Green, Research Governance Officer J.A.Green@lboro.ac.uk
Manchester 
Metropolitan 
University
Professor Richard Greene, Pro-Vice-Chancellor 
for Research and Knowledge Exchange
via Alexa Stewart a.stewart@
mmu.ac.uk
Middlesex University Director of Research and Director of 
Knowledge Transfer
Newcastle University Professor Brian Walker, Pro-Vice-Chancellor 
for Research Strategy and Resources
Brian.Walker@ncl.ac.uk
Northumbria 
University
Ruth Hattam, Deputy Director (Research) ruth.hattam@northumbria.ac.uk
Nottingham Trent 
University
Professor Yvonne Barnett, Senior Pro Vice-
Chancellor (Research)
ResearchOffice@ntu.ac.uk
Oxford Brookes 
University
Professor Linda King, Pro Vice-Chancellor 
Research and Global Partnerships (oversees 
policy)
laking@brookes.ac.uk Sarah Taylor, Research Support Director 
(point of contact for RI) (staylor@
brookes.ac.uk)
Plymouth Marjon 
University
Professor Andrew Edwards, Director of 
Research
aedwards@marjon.ac.uk
61
 R
esearch
 in
teg
rity 
Institution Research integrity responsibility Contact address Other research integrity contact
Plymouth University Dr John Martin, Secretary of the University 
Research Ethics Committee
J.Martin-2@plymouth.ac.uk
Queen Margaret 
University
Kim Stuart, Head of Research and KE 
Development
kstuart@qmu.ac.uk
Queen Mary 
University of London
Vice Principal for Research Not provided
Queen’s University 
Belfast
Pro-Vice-Chancellor for Research, 
Postgraduates and Enterprise, via Mrs Louise 
Dunlop, Head of Research Governance, Ethics 
and Integrity
l.h.dunlop@qub.ac.uk researchgovernance@qub.ac.uk
Regent’s University 
London
Not provided Not provided
Robert Gordon 
University
Professor Paul Hagan, Vice-Principal 
(Research)
Royal College of Art Director of Research and Innovation and 
Director of Adademic Development
Royal College of 
Music, London
Professor Richard Wistreich, Director of 
Research
richard.wistreich@rcm.ac.uk
Royal Holloway, 
University of London
Professor Katie Normington k.normington@rhul.ac.uk
Royal Veterinary 
College
Professor Jonathan Elliott, Vice Principal for 
Research and Innovation
jelliott@rvc.ac.uk
Sheffield Hallam 
University
Professor Ann Macaskill, Head of Research 
Ethics and Integrity
researchsupport@shu.ac.uk
SOAS, University of 
London
Pro-Director for Research Not specified
Southampton Solent 
University
Chair of the Research, Innovation & Enterprise 
Committee
St George’s, 
University of London
Professor Mark Fisher, Deputy Principal for 
Research
lfisher@sgul.ac.uk
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Institution Research integrity responsibility Contact address Other research integrity contact
Staffordshire 
University
Professor Martin Jones, Deputy Vice 
Chancellor
martin.jones@staffs.ac.uk
Swansea University Dr Jeanette Hewitt, Chair of University 
Research Ethics & Governance sub-committee
j.l.hewitt@swansea.ac.uk researchintegrity@swansea.ac.uk; 
researchmisconduct@swansea.ac.uk
Teesside University Dr Andrew Rawnsley, Research Governance & 
Training Manager
a.rawnsley@tees.ac.uk
The Glasgow School 
of Art
Colin Kirkpatrick, Head of Research and 
Enterprise
c.kirkpatrick@gsa.ac.uk
The London School 
of Economics and 
Political Science
Professor Julia Black, Pro-Director, Research j.black@lse.ac.uk Lyn Grove, Research Ethics Manager 
(l.grove@lse.ac.uk)
The Open University Professor Kevin Hetherington, Pro-Vice-
Chancellor (Research and Academic Strategy)
PVC-RAS@open.ac.uk
The Royal Central 
School of Speech & 
Drama
Dr Stephen Farrier, Chair of the Research 
Ethics Sub-committee
Not provided
The University of 
Buckingham
Not provided Not provided
The University of 
Manchester
Vice-President for Research via Mrs April Lockyer, Research 
Governance and Integrity 
Manager (April.Lockyer@
Manchester.ac.uk)
The University of 
Nottingham
Soma Mukherjee, Research Integrity Manager soma.mukherjee@nottingham.
ac.uk
The University of 
West London
Professor Joëlle Fanghanel, Pro Vice 
Chancellor (Academic)
Not provided
Trinity Laban 
Conservatoire of 
Music and Dance
Dr Jonathan Clark, Head of Research j.clark@trinitylaban.ac.uk
Ulster University Nick Curry, Head of Research Governance n.curry@ulster.ac.uk
63
 R
esearch
 in
teg
rity 
Institution Research integrity responsibility Contact address Other research integrity contact
University College 
London
Ms Rowena Lamb, Head of Research Integrity 
(information on research integrity)
researchintegrity@ucl.ac.uk
University of 
Aberdeen
Professor Marion Campbell, Vice Principal for 
Research and Knowledge Exchange
m.k.campbell@abdn.ac.uk
University of Bath Professor Jonathan Knight, Pro-Vice-
Chancellor (Research)
s.m.eglinton@bath.ac.uk
University of 
Bedfordshire
Director of Research Development Not provided
University of 
Birmingham
Professor Tim Softley, Pro-Vice-Chancellor for 
Research and Knowledge Transfer
Not provided Dr Sean Jennings, Head of Research 
Governance and Ethics (s.jennings@
bham.ac.uk)
University of Bolton Dr Andy Graham, Executive Dean, Research 
and Graduate School
a.graham@bolton.ac.uk
University of 
Bradford
Professor John Bridgeman, Pro-Vice-
Chancellor (Research and Knowledge Transfer)
via Pam McClaren p.mclaren@
bradford.ac.uk
University of 
Brighton
Hilary Ougham, Research Policy Officer h.a.ougham@brighton.ac.uk; ext 
4184
University of Bristol Professor Nishan Canagarajah, Pro Vice-
Chancellor for Research and Enterprise
research-governance@bristol.
ac.uk
University of 
Cambridge
Pro-Vice-Chancellor for Research researchintegrity@admin.cam.
ac.uk
Dr Rhys Morgan, Research Governance 
and Integrity Officer (rhys.morgan@
admin.cam.ac.uk)
University of Central 
Lancashire
Emma Sandon-Hesketh, University Officer for 
Ethics
officerforethics@uclan.ac.uk
University of Chester Professor Nick Avis, Pro Vice-Chancellor for 
Research and Knowledge Transfer
Not provided
University of 
Chichester
Professor Catherine Harper, Deputy Vice 
Chancellor
c.harper@chi.ac.uk Dr Andy Dixon, Director of Research 
(a.dixon@chi.ac.uk)
University of 
Cumbria
Director of Research and Head of the 
Graduate School
Not provided
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Institution Research integrity responsibility Contact address Other research integrity contact
University of Derby Head of Research Not provided
University of Dundee Professor Alan Fairlamb, Chair of the 
Reseaerch Governance and Policy 
Subcommittee
a.h.fairlamb@dundee.ac.uk Dr Clive Randall, Research Policy 
Manager (c.randall@dundee.ac.uk)
University of East 
Anglia
Professor Fiona Lettice, Pro-Vice-Chancellor 
for Research and Innovation
fiona.lettice@uea.ac.uk ResearchIntegrity@uea.ac.uk
University of East 
London
Dr Lisa Mooney, Pro Vice-Chancellor for 
Research and Knowledge Exchange and Chair 
of the University of East London’s Research 
Ethics Committee
L.Mooney@uel.ac.uk Catherine Fieulleteau, Research Integrity 
and Ethics Manager (C.fieulleteau@uel.
ac.uk)
University of 
Edinburgh
Professor Jonathan Seckl, Chair of Research 
Policy Group
j.seckl@ed.ac.uk
University of Essex Pro-Vice-Chancellor (Research) Ms Sarah Manning-Press, Research 
Governance and Planning Manager 
(sarahm@essex.ac.uk)
University of Exeter Gail Seymour, Research Ethics and Governance 
Manager
g.m.seymour@exeter.ac.uk
University of 
Glasgow
Professor John Briggs, Vice Principal and Clerk 
of Senate
John.Briggs@glasgow.ac.uk
University of 
Gloucestershire
Deputy Vice Chancellor Not provided
University of 
Greenwich
Secretary, University Research Ethics 
Committee
researchethics@gre.ac.uk
University of 
Hertfordshire
Dr Susan Grey, Director of Research Degrees 
and Director of the Doctoral College, 
Institutional Lead Research Integrity, Point of 
contact for whistle-blowing
s.grey@herts.ac.uk
University of 
Huddersfield
Professor Tim Thornton, Deputy Vice 
Chancellor
t.j.thornton@hud.ac.uk
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Institution Research integrity responsibility Contact address Other research integrity contact
University of Hull Dr David Richards, Pro-Vice Chancellor 
(Research and Enterprise)
pvc-re@hull.ac.uk researchgovernance@hull.ac.uk
University of Kent Professor Philippe De Wilde, Deputy Vice-
Chancellor Research & Innovation
p.dewilde@kent.ac.uk Nicole Palmer, Research Ethics & 
Governance Officer (n.r.palmer@kent.
ac.uk)
University of Leeds Professor Lisa Roberts, Deputy Vice-
Chancellor: Research & Innovation
DVC.Res@leeds.ac.uk
University of 
Leicester
Professor Mark Jobling, Chair of Research 
Ethics and Integrity Training Group, with Dr 
Juliet Bailey, Research and Enterprise Division
maj4@le.ac.uk
University of Lincoln Professor Andrew Hunter, Senior Deputy 
Vice Chancellor – Research, Innovation and 
Enterprise
ahunter@lincoln.ac.uk
University of 
Liverpool
Professor Sarah O’Brien, Chair of the 
University Research Governance Committee
integrity@liverpool.ac.uk
University of London Professor Rick Rylance, Dean and Chief 
Executive of the School of Advanced Study
Not provided
University of 
Northampton
Mrs Jane Bunce, Director of Student and 
Academic Services
Jane.Bunce@northampton.ac.uk
University of Oxford Professor Ewan McKendrick, Registrar 
(oversight), Ms Kathryn Dally (contact point)
Kathryn.dally@admin.ox.ac.uk
University of 
Portsmouth
Professor Pal Ahluwalia, Pro Vice-Chancellor 
(research & Innovation)
pal.ahluwalia@port.ac.uk Denise Teasdale, Research Manager 
in Research and Innovation Services 
(denise.teasdale@port.ac.uk)
University of 
Reading
Dr Richard Messer, University Secretary r.j.messer@reading.ac.uk
University of 
Roehampton
Deputy Provost for Research and External 
Engagement
Not provided
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Institution Research integrity responsibility Contact address Other research integrity contact
University of Salford Deputy Vice Chancellor Direct questions to Dr Jo 
Cresswell, Associate Director 
Research (j.e.cresswell@salford.
ac.uk)
research-misconduct@salford.ac.uk
University of 
Sheffield
Professor Dave Petley, Vice-President 
(Research and Innovation)
d.n.petley@sheffield.ac.uk Lindsay Unwin, Ethics and Integrity 
Officer (L.V.Unwin@sheffield.ac.uk)
University of South 
Wales
Pro Vice-Chancellor Research Not provided
University of 
Southampton
Professor Mark Spearing, Vice President 
Research and Enterprise
via Fiona Wright F.D.Wright@
southampton.ac.uk
Diana Galpin, Head of IP, Contracts and 
Policy (researchintegrity@soton.ac.uk)
University of St 
Andrews
Professor J. Derek Woollins, Vice Principal 
(Research and Innovation)
researchintegrity@st-andrews.
ac.uk
University of Stirling Director of Research & Innovation Services Not provided Rachel Beaton, Research Policy Officer 
(rachel.beaton@stir.ac.uk)
University of 
Strathclyde
Associate Principal responsible for Research research-integrity@strath.ac.uk
University of 
Sunderland
Martin Finlayson, Head of the University 
Research Office
martin.finlayson@sunderland.
ac.uk
University of Surrey Associate Deans (Research) for each faculty 
and the Director of the Doctoral College
Separate contact details for each 
faculty
rigo@surrey.ac.uk
University of Sussex Professor Saul Becker, Deputy Vice-Chancellor Not provided
University of the 
Arts London
Professor Oriana Baddeley o.baddeley@arts.ac.uk
University of the 
Highlands and 
Islands
Neil Simco, Acting Vice-Principal (Research) neil.simco@uhi.ac.uk
University of the 
West of England, 
Bristol
Ms Ros Rouse, Research Governance Manager Ros.Rouse@uwe.ac.uk researchgovernance@uwe.ac.uk
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Institution Research integrity responsibility Contact address Other research integrity contact
University of the 
West of Scotland
Prof Ehsan Mesbahi, Vice Principal and Pro 
Vice Chancellor (Academic)
Ehsan.Mesbahi@uws.ac.uk
University of Wales Deputy Vice-Chancellor (Research and 
Innovation)
Not provided
University of Wales 
Trinity Saint David
Professor Jill Venus, Chair of the Ethics 
Committee
j.venus@uwtsd.ac.uk
University of 
Warwick
Professor Stephen Jarvis, Deputy Pro-
Vice-Chancellor (Research Infrastructure & 
Governance)
S.A.Jarvis@warwick.ac.uk Jane Prewett, Head of Research 
Governance and Deputy Director 
Research & Impact Services (jane.
prewett@warwick.ac.uk)
University of 
Westminster
Professor Graham Megson (Acting Vice 
Chancellor)
First point of contact is Bob Odle, 
Research Quality and Standards 
Manager b.odle@westminster.
ac.uk.
University of 
Winchester
Professor Kate Adams, Director of Research & 
Knowledge Exchange
Kate.Adams@winchester.ac.uk
University of 
Wolverhampton
Dean of Research, as Chair of the Ethics 
Committee
Not provided
University of 
Worcester
Professor Derek Peters, Chair of the Ethics and 
Research Governance Committee
d.peters@worc.ac.uk
University of York Professor Deborah Smith, Pro-Vice-Chancellor 
for Research
PVC-Research@york.ac.uk Research Strategy and Policy Manager, 
Anna Grey (anna.grey@york.ac.uk)
York St John 
University
Not provided Not provided
Source: Survey responses (RES0059), university webpages
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Institution Publishes report? (as at 
date of response)
Reason given for non-
publication
2015/16 Report 
hyperlink
2016/17 Report 
hyperlink
General info 
webpage on 
research integrity
Aberystwyth University Yes 2016/17 Report General info
Anglia Ruskin University Yes 2015/16 Report 2016/17 Report General info
Aston University Will None None General info
Bangor University Will None None General info
Bath Spa University Yes 2015/16 Report General info
Birkbeck, University of 
London
No Confidentiality None None General info
Birmingham City University Will None None
Bournemouth University Yes 2016/17 Report General info
Brunel University London Yes 2016/17 Report General info
Buckinghamshire New 
University
Yes 2016/17 Report General info
Canterbury Christ Church 
University
Yes 2015/16 Report General info
Cardiff Metropolitan 
University (UWIC)
No No nil return None None General info
Cardiff University Yes 2016/17 Report General info
City, University of London Yes 2016/17 Report General info
Coventry University Yes 2016/17 Report General info
Cranfield University Will None None General info
De Montfort University Yes 2015/16 Report General info
Durham University Yes 2016/17 Report General info
Edge Hill University Yes 2015/16 Report 2016/17 Report General info
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Institution Publishes report? (as at 
date of response)
Reason given for non-
publication
2015/16 Report 
hyperlink
2016/17 Report 
hyperlink
General info 
webpage on 
research integrity
Edinburgh Napier 
University
Yes 2015/16 Report 2016/17 Report General info
Falmouth University Will None None General info
Glasgow Caledonian 
University
No No nil return None None General info
Glyndwr University Yes 2015/16 Report 2016/17 Report General info
Goldsmiths, University of 
London
Yes 2015/16 Report 2016/17 Report General info
Guildhall School of Music 
and Drama
No No nil return None None
Heriot-Watt University Will None None
Heythrop College Yes 2016/17 Report
Imperial College London Yes 2015/16 Report 2016/17 Report General info
Keele University Yes 2015/16 Report 2016/17 Report General info
King’s College London Yes 2015/16 Report General info
Kingston University Yes 2016/17 Report General info
Lancaster University Yes 2016/17 Report General info
Leeds Beckett University Will None None General info
Leeds Trinity University No No nil return None None
Liverpool Hope University Yes [2017/18 report] General info
Liverpool John Moores 
University
No Assumed figures 
reported elsewhere 
were public
None None
London Business School No No nil return None None
London Metropolitan 
University
No No nil return None None
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Institution Publishes report? (as at 
date of response)
Reason given for non-
publication
2015/16 Report 
hyperlink
2016/17 Report 
hyperlink
General info 
webpage on 
research integrity
London School of Hygiene 
and Tropical Medicine
Yes 2015/16 Report 2016/17 Report General info
London South Bank 
University
Will None None General info
Loughborough University Yes 2015/16 Report 2016/17 Report General info
Manchester Metropolitan 
University
Yes 2015/16 Report 2016/17 Report
Middlesex University No Not appropriate None None
Newcastle University Will None None General info
Northumbria University Yes 2015/16 Report 2016/17 Report General info
Nottingham Trent 
University
Yes 2015/16 Report 2016/17 Report General info
Oxford Brookes University Yes 2016/17 Report General info
Plymouth Marjon University Will None None General info
Plymouth University Yes 2016/17 Report General info
Queen Margaret University Yes 2016/17 Report General info
Queen Mary University of 
London
No Not provided None None General info
Queen’s University Belfast Yes 2015/16 Report 2016/17 Report General info
Regent’s University London Will None None
Robert Gordon University Will None None General info
Royal College of Art No No nil return None None
Royal College of Music, 
London
No No nil return None None General info
Royal Holloway, University 
of London
Yes None Short statement on 
general info webpage
General info
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Institution Publishes report? (as at 
date of response)
Reason given for non-
publication
2015/16 Report 
hyperlink
2016/17 Report 
hyperlink
General info 
webpage on 
research integrity
Royal Veterinary College Will None None General info
Sheffield Hallam University Yes 2015/16 Report 2016/17 Report General info
SOAS, University of London Will None None General info
Southampton Solent 
University
No No nil return None None General info
St George’s, University of 
London
Yes 2015/16 Report 2016/17 Report General info
Staffordshire University No Not provided None None General info
Swansea University Will None None General info
Teesside University Yes 2015/16 Report 2016/17 Report General info
The Glasgow School of Art No No nil return None None
The London School of 
Economics and Political 
Science
Will None None General info
The Open University Yes 2016/17 Report General info
The Royal Central School of 
Speech & Drama
Yes 2016/17 Report General info
The University of 
Buckingham
No No nil return None None
The University of 
Manchester
Yes 2016/17 Report General info
The University of 
Nottingham
Yes 2015/16 Report General info
The University of West 
London
No Reviewing procedures None None
Trinity Laban Conservatoire 
of Music and Dance
No Not provided None None
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Institution Publishes report? (as at 
date of response)
Reason given for non-
publication
2015/16 Report 
hyperlink
2016/17 Report 
hyperlink
General info 
webpage on 
research integrity
Ulster University Yes 2015/16 Report General info
University College London Yes 2015/16 Report General info
University of Aberdeen Yes 2015/16 Report General info
University of Bath Yes None 2016/17 Report General info
University of Bedfordshire No Confidentiality None None
University of Birmingham Yes 2015/16 Report 2016/17 Report General info
University of Bolton Yes 2016/17 Report General info
University of Bradford No Reviewing procedures None None
University of Brighton Yes 2015/16 Report
University of Bristol Yes 2015/16 Report General info
University of Cambridge Yes 2015/16 Report 2016/17 Report General info
University of Central 
Lancashire
Will None To be published General info
University of Chester Will None 2016/17 Report General info
University of Chichester No No nil return None None General info
University of Cumbria No No nil return None None General info
University of Derby Will None 2016/17 Report General info
University of Dundee Yes 2015/16 Report 2016/17 Report General info
University of East Anglia Yes 2016/17 Report General info
University of East London Yes 2016/17 Report General info
University of Edinburgh Yes 2015/16 Report General info
University of Essex Will None 2016/17 Report General info
University of Exeter Yes 2016/17 Report General info
University of Glasgow Yes 2015/16 Report 2016/17 Report General info
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Institution Publishes report? (as at 
date of response)
Reason given for non-
publication
2015/16 Report 
hyperlink
2016/17 Report 
hyperlink
General info 
webpage on 
research integrity
University of 
Gloucestershire
No No nil return None None General info
University of Greenwich Will None None General info
University of Hertfordshire Yes 2015/16 Report General info
University of Huddersfield Yes 2015/16 Report 2016/17 Report General info
University of Hull Yes 2015/16 Report 2016/17 Report General info
University of Kent Yes 2016/17 Report General info
University of Leeds Yes 2015/16 Report 2016/17 Report General info
University of Leicester Yes 2015/16 Report 2016/17 Report General info
University of Lincoln No Not necessary or 
proportionate
None None General info
University of Liverpool Yes 2016/17 Report General info
University of London No Not provided None None General info
University of Northampton Yes 2016/17 Report General info
University of Oxford Yes 2015/16 Report 2016/17 Report General info
University of Portsmouth Yes 2016/17 Report General info
University of Reading No Reviewing procedures None None
University of Roehampton Yes 2016/17 Report General info
University of Salford Yes Number of cases 
disclosed on general 
information page
General info
University of Sheffield Yes 2015/16 Report 2016/17 Report General info
University of South Wales No Confidentiality None None General info
University of Southampton Yes 2015/16 Report 2016/17 Report General info
University of St Andrews Yes 2015/16 Report 2016/17 Report General info
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Institution Publishes report? (as at 
date of response)
Reason given for non-
publication
2015/16 Report 
hyperlink
2016/17 Report 
hyperlink
General info 
webpage on 
research integrity
University of Stirling No No nil return None None General info
University of Strathclyde Yes 2016/17 Report General info
University of Sunderland Yes 2016/17 Report General info
University of Surrey Yes 2016/17 Report General info
University of Sussex Yes 2016/17 Report
University of the Arts 
London
Yes 2015/16 Report 2016/17 Report General info
University of the Highlands 
and Islands
No Not provided None None General info
University of the West of 
England, Bristol
Will None None General info
University of the West of 
Scotland
No No nil return None None
University of Wales No No nil return None None
University of Wales Trinity 
Saint David
No No nil return None None General info
University of Warwick Yes 2015/16 Report 2016/17 Report General info
University of Westminster Yes 2016/17 Report General info
University of Winchester No No nil return None None General info
University of 
Wolverhampton
Will None To be published General info
University of Worcester Yes 2015/16 Report General info
University of York Yes 2015/16 Report 2016/17 Report General info
York St John University No No nil return None None General info
Source: Survey responses (RES0058), university webpages
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Formal minutes
Tuesday 26 June 2018
Members present:
Norman Lamb, in the Chair
Vicky Ford
Bill Grant
Darren Jones
Liz Kendall
Stephen Metcalfe
Carol Monaghan
Graham Stringer
Draft Report (Research integrity), proposed by the Chair, brought up and read.
Ordered, That the draft Report be read a second time, paragraph by paragraph.
Paragraphs 1 to 128 read and agreed to.
Summary and Annex agreed to.
Resolved, That the Report be the Sixth Report of the Committee to the House.
Ordered, That the Chair make the Report to the House.
Ordered, That embargoed copies of the Report be made available, in accordance with the 
provisions of Standing Order No. 134.
[Adjourned till Thursday 28 June at 2.30 pm
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Witnesses
The following witnesses gave evidence. Transcripts can be viewed on the inquiry publications 
page of the Committee’s website.
Tuesday 24 October 2017 Question number
Professor Dorothy Bishop, Professor of Developmental Neuropsychology, 
University of Oxford; Dr Arnaud Vaganay, Director, Meta-Lab; and Professor 
Dame Ottoline Leyser FRS, former Chair, Steering Group on the Culture of 
Scientific Research, Nuffield Council on Bioethics Q1–47
Dr Elizabeth Wager, Publications Consultant, Sideview, and Honorary Co-
ordinator, the REWARD Alliance; Professor Sir Ian Diamond, Research Policy 
Network, Universities UK; Professor Ian Walmsley, Pro Vice Chancellor 
for Research Working Group, Russell Group; and Dr Peter Wilmshurst, 
Consultant Cardiologist, Royal Stoke University Hospital Q48–114
Tuesday 21 November 2107
Professor David Hand, Royal Statistical Society; Dr Damian Pattinson, Vice 
President of Publishing Innovation, Research Square; and Wendy Appleby, 
Registrar and Head of Student & Registry Services, University College 
London Q115–212
Dr Trish Groves, Director of Academic Outreach, British Medical Journal; Dr 
Elizabeth Moylan, Senior Editor for Peer Review Strategy and Innovation, 
BioMedCentral (representing the Committee on Publication Ethics); Catriona 
Fennell, Director of Publishing Services, Elsevier (representing The Publishers 
Association); and Dr Alyson Fox, Director of Grants Management, Wellcome 
Trustl Q213–276
Monday 4 December 2107
Dr Ivan Oransky, Co-Founder, Retraction Watch, and Distinguished Writer 
in Residence, New York University Arthur Carter Journalism Institute; and 
Professor C K Gunsalus, Director, US National Centre for Professional and 
Research Ethics Q277–310
Dr Ben Goldacre, DataLab, Department of Primary Care, University of 
Oxford; Dr Simon Kolstoe, Senior Lecturer and University Ethics Adviser, 
University of Portsmouth, and Independent Chair of Hampshire A (NHS) and 
the MOD research ethics committees; and Síle Lane, Head of International 
Campaigns and Policy, Sense about Science Q311–360
Tuesday 30 January 2018
Professor Sir Bernard Silverman, Chair of Trustees, UK Research Integrity 
Office; and James Parry, Chief Executive, UK Research Integrity Office Q361–433
Dr Tony Peatfield, Director of Corporate Affairs, Medical Research Council, 
and Chairman, RCUK Good Research Conduct Network; and Dr Steven Hill, 
Head of Research Policy, Higher Education Funding Council for England Q434–496
Professor Jonathan Montgomery, Chair, Health Research Authority Q497–531
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Tuesday 6 March 2018
Professor Sir Mark Walport, Chief Executive, UK Research and Innovation 
(UKRI) Q532–615
Tuesday 8 May 2018
Mr Sam Gyimah MP, Minister for Universities, Science, Research and 
Innovation; and Dr Patrick Vallance, Government Chief Scientific Adviser 
and Head of Government Science and Engineering Profession, Government 
Office for Science Q616–693
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Published written evidence
The following written evidence was received and can be viewed on the inquiry publications 
page of the Committee’s website.
RES numbers are generated by the evidence processing system and so may not be complete
1 Australian Research Council (RES0050)
2 Bullied into Bad Science (RES0002)
3 Carmen Helena Coxon (RES0035)
4 Cell and Gene Therapy Catapult (RES0033)
5 Cell and Gene Therapy Catapult (RES0054)
6 Collated responses from Departmental Chief Scientists (RES0048)
7 Collated responses from UUK members regarding Concordat compliance (RES0059)
8 Department for Business, Energy and Industrial Strategy (RES0057)
9 Dr Dominic Edward (RES0027)
10 Dr Gesche Huebner (RES0010)
11 Dr Hugh Llewelyn (RES0024)
12 Dr Paola Di Maio (RES0039)
13 Dr Paul Marchant (RES0042)
14 Dr Paul Taylor and Dr Daniel Barr, RMIT University, Melbourne (RES0051)
15 Dr Peter Wilmshurst (RES0025)
16 Dr Sarah Starkey (RES0018)
17 Dr Simon Kolstoe (RES0030)
18 Dr Venu Kumar (RES0012)
19 EIS (RES0013)
20 Health Research Authority (RES0040)
21 Health Research Authority (RES0047)
22 HealthWatch UK & Universities Allied for Essential Medicines UK & TranspariMED & 
Dr Simon Kolstoe (joint submission) (RES0008)
23 Innovate UK (RES0044)
24 Mathias Willumsen (RES0043)
25 Medical Research Council (RES0032)
26 Medical Research Council (RES0041)
27 Meta-Lab (RES0021)
28 Miss Tessa Burrington (RES0011)
29 Professor David J Hand (RES0028)
30 Professor Donald S Kornfeld (RES0037)
31 Professor Dorothy Bishop (RES0019)
32 Professor Marcus Munafò (RES0049)
33 Professor Patricia Murray and Raphael Lévy (RES0022)
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34 Professor Patricia Murray and Raphael Lévy (RES0045)
35 Professor Patricia Murray and Raphael Lévy (RES0053)
36 Roger Shinton (RES0046)
37 Russell Group (RES0056)
38 Samuel Denyer and Dr Simon Peck (RES0031)
39 Sense about Science (RES0034)
40 STOPAIDS, HealthWatch UK, Universities Allied for Essential Medicines UK and 
TranspariMED (RES0036)
41 The Academy of Medical Sciences (RES0005)
42 The Royal Society (RES0014)
43 Tony Mayer, Professor Lex Bouter, and Professor Nick Steneck (RES0026)
44 TranspariMED (RES0058)
45 UK Research and Innovation (RES0055)
46 UK Research Integrity Office (RES0023)
47 UK Research Integrity Office (RES0052)
48 Universities UK (RES0020)
49 Wendy Appleby on behalf of UCL (RES0029)
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List of Reports from the Committee 
during the current Parliament
All publications from the Committee are available on the publications page of the 
Committee’s website. The reference number of the Government’s response to each Report 
is printed in brackets after the HC printing number.
Session 2017–19
First Report Pre-appointment hearing: chair of UK Research & 
Innovation and executive chair of the Medical Research 
Council
HC 747
Second Report Brexit, science and innovation HC 705
Third Report Genomics and genome editing in the NHS HC 349
Fourth Report Algorithms in decision-making HC 351
Fifth Report Biometrics strategy and forensic services HC 800
First Special Report Science communication and engagement: Government 
Response to the Committee’s Eleventh Report of 
Session 2016–17
HC 319
Second Special Report Managing intellectual property and technology 
transfer: Government Response to the Committee’s 
Tenth Report of Session 2016–17
HC 318
Third Special Report Industrial Strategy: science and STEM skills: 
Government Response to the Committee’s Thirteenth 
Report of Session 2016–17
HC 335
Fourth Special Report Science in emergencies: chemical, biological, 
radiological or nuclear incidents: Government 
Response to the Committee’s Twelfth Report of 
Session 2016–17
HC 561
Fifth Special Report Brexit, science and innovation: Government Response 
to the Committee’s Second Report
HC 1008
